<SEC-DOCUMENT>0001628280-22-010921.txt : 20220428
<SEC-HEADER>0001628280-22-010921.hdr.sgml : 20220428
<ACCEPTANCE-DATETIME>20220428071948
ACCESSION NUMBER:		0001628280-22-010921
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20220428
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220428
DATE AS OF CHANGE:		20220428

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BAXTER INTERNATIONAL INC
		CENTRAL INDEX KEY:			0000010456
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				360781620
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-04448
		FILM NUMBER:		22862180

	BUSINESS ADDRESS:	
		STREET 1:		ONE BAXTER PKWY
		STREET 2:		DF2-1W
		CITY:			DEERFIELD
		STATE:			IL
		ZIP:			60015
		BUSINESS PHONE:		8479482000

	MAIL ADDRESS:	
		STREET 1:		ONE BAXTER PARKWAY
		STREET 2:		DF2-1W
		CITY:			DEERFIELD
		STATE:			IL
		ZIP:			60015

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BAXTER TRAVENOL LABORATORIES INC
		DATE OF NAME CHANGE:	19880522

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BAXTER LABORATORIES INC
		DATE OF NAME CHANGE:	19760608
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>bax-20220428.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:b58d54f6-cdfc-4a1b-bd93-899aabf6e1c3,g:5b5b1c76-46ea-4a42-acb6-696751fef255,d:24ea93e56c084a7189f356eebb530663--><html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:bax="http://www.baxter.com/20220428" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns="http://www.w3.org/1999/xhtml" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bax-20220428</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M180L2ZyYWc6ZjBmNDkwYjA3Y2MwNDMwNGIyMDI5MzYyOTBhYTAwMTMvdGFibGU6NTllNzE5ZWI2ZDg0NGM0M2FjMDEyZWRkMDc0OTdlNjMvdGFibGVyYW5nZTo1OWU3MTllYjZkODQ0YzQzYWMwMTJlZGQwNzQ5N2U2M18yLTEtMS0xLTc3MDMx_82bfd8f7-e90a-499c-b58c-528b1ff48378">0000010456</ix:nonNumeric><ix:nonNumeric contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M180L2ZyYWc6ZjBmNDkwYjA3Y2MwNDMwNGIyMDI5MzYyOTBhYTAwMTMvdGFibGU6NTllNzE5ZWI2ZDg0NGM0M2FjMDEyZWRkMDc0OTdlNjMvdGFibGVyYW5nZTo1OWU3MTllYjZkODQ0YzQzYWMwMTJlZGQwNzQ5N2U2M18zLTEtMS0xLTc3MDMx_f5dc4a14-1ede-4b57-b389-fb8490a07823">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bax-20220428.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-28</xbrli:startDate><xbrli:endDate>2022-04-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i381710d4910e422b97fea75cdcf8e78f_D20220428-20220428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XCHI</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:CommonStock1.00PerValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-28</xbrli:startDate><xbrli:endDate>2022-04-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief8d3a11266e481c983d30b0238d7b07_D20220428-20220428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:CommonStock1.00PerValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-28</xbrli:startDate><xbrli:endDate>2022-04-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7c6c94e8b81438ea60699f91e73e50f_D20220428-20220428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes13Due2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-28</xbrli:startDate><xbrli:endDate>2022-04-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3990410f47145c99222032eee574cda_D20220428-20220428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes13Due2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-28</xbrli:startDate><xbrli:endDate>2022-04-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id93d7d4374c74218be5e80c4961e0172_D20220428-20220428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes04Due2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-28</xbrli:startDate><xbrli:endDate>2022-04-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idde09224ed154ef6989119f50debc00a_D20220428-20220428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes395Due2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-28</xbrli:startDate><xbrli:endDate>2022-04-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73fcc3c461804f26a10565d678147c10_D20220428-20220428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000010456</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes173Due2031Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-28</xbrli:startDate><xbrli:endDate>2022-04-28</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i24ea93e56c084a7189f356eebb530663_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:20pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGV4dHJlZ2lvbjozZmQ5MTk0YzA3YTA0M2Q0ODM0MzI1NjZjZjliN2I3Yl84Mg_6c7b031d-2615-44cc-ae40-f294b2b6786d">8-K</ix:nonNumeric> </span></div><div style="margin-top:20pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PURSUANT TO SECTION&#160;13 OR 15(D) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:20pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGV4dHJlZ2lvbjozZmQ5MTk0YzA3YTA0M2Q0ODM0MzI1NjZjZjliN2I3Yl8yMjM_25de28fa-7457-4580-95e4-56adceed9c0a">April 28, 2022</ix:nonNumeric></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6NjMyMWU3NTYzMTIzNGEwMGJmYTNjOGZjMWViYTc5YjcvdGFibGVyYW5nZTo2MzIxZTc1NjMxMjM0YTAwYmZhM2M4ZmMxZWJhNzliN18wLTAtMS0xLTc3MDMx_d14818dc-882c-4377-b826-5e4e56142dcf">Baxter International Inc.</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Exact name of registrant as specified in its charter)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6NjMyMWU3NTYzMTIzNGEwMGJmYTNjOGZjMWViYTc5YjcvdGFibGVyYW5nZTo2MzIxZTc1NjMxMjM0YTAwYmZhM2M4ZmMxZWJhNzliN18zLTAtMS0xLTc3MDMx_d72221a5-220c-4f38-bd1c-f3ee3f3b348c">Delaware</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6NjMyMWU3NTYzMTIzNGEwMGJmYTNjOGZjMWViYTc5YjcvdGFibGVyYW5nZTo2MzIxZTc1NjMxMjM0YTAwYmZhM2M4ZmMxZWJhNzliN182LTAtMS0xLTc3MDMx_3cc12792-f9b8-47d1-8daa-74511976307d">1-4448</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6NjMyMWU3NTYzMTIzNGEwMGJmYTNjOGZjMWViYTc5YjcvdGFibGVyYW5nZTo2MzIxZTc1NjMxMjM0YTAwYmZhM2M4ZmMxZWJhNzliN182LTEtMS0xLTc3MDMx_904ad2a7-e604-4b86-b6ea-f0053de1e83c">36-0781620</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6NjMyMWU3NTYzMTIzNGEwMGJmYTNjOGZjMWViYTc5YjcvdGFibGVyYW5nZTo2MzIxZTc1NjMxMjM0YTAwYmZhM2M4ZmMxZWJhNzliN185LTAtMS0xLTc3MDMxL3RleHRyZWdpb246YzBjYTA5NGQ1ODUyNDJkMWE4ZjBmM2FiZTQ4MjU4MmNfNA_9ed31d9a-e5c0-4008-a254-4466da892217">One Baxter Parkway</ix:nonNumeric>, <ix:nonNumeric contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6NjMyMWU3NTYzMTIzNGEwMGJmYTNjOGZjMWViYTc5YjcvdGFibGVyYW5nZTo2MzIxZTc1NjMxMjM0YTAwYmZhM2M4ZmMxZWJhNzliN185LTAtMS0xLTc3MDMxL3RleHRyZWdpb246YzBjYTA5NGQ1ODUyNDJkMWE4ZjBmM2FiZTQ4MjU4MmNfOA_7889c42e-5860-4f77-adfc-721a1bd06126">Deerfield</ix:nonNumeric>, <ix:nonNumeric contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6NjMyMWU3NTYzMTIzNGEwMGJmYTNjOGZjMWViYTc5YjcvdGFibGVyYW5nZTo2MzIxZTc1NjMxMjM0YTAwYmZhM2M4ZmMxZWJhNzliN185LTAtMS0xLTc3MDMxL3RleHRyZWdpb246YzBjYTA5NGQ1ODUyNDJkMWE4ZjBmM2FiZTQ4MjU4MmNfMTI_379c2e88-b2a7-44f1-b188-bb8ed994e9de">Illinois</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6NjMyMWU3NTYzMTIzNGEwMGJmYTNjOGZjMWViYTc5YjcvdGFibGVyYW5nZTo2MzIxZTc1NjMxMjM0YTAwYmZhM2M4ZmMxZWJhNzliN185LTEtMS0xLTc3MDMx_ec201de6-ea63-4108-8443-594ab5ecc9bc">60015</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(<ix:nonNumeric contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6NjMyMWU3NTYzMTIzNGEwMGJmYTNjOGZjMWViYTc5YjcvdGFibGVyYW5nZTo2MzIxZTc1NjMxMjM0YTAwYmZhM2M4ZmMxZWJhNzliN18xMi0wLTEtMS03NzAzMS90ZXh0cmVnaW9uOjA5N2RkZDEzMzBlNzRlOWM5ZDM4OGFlNmI4MGYzOTk2XzU_3fe583b4-f1cc-49de-ba85-4ad7e69848f7">224</ix:nonNumeric>)<ix:nonNumeric contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6NjMyMWU3NTYzMTIzNGEwMGJmYTNjOGZjMWViYTc5YjcvdGFibGVyYW5nZTo2MzIxZTc1NjMxMjM0YTAwYmZhM2M4ZmMxZWJhNzliN18xMi0wLTEtMS03NzAzMS90ZXh0cmVnaW9uOjA5N2RkZDEzMzBlNzRlOWM5ZDM4OGFlNmI4MGYzOTk2Xzg_2677c541-e354-4038-a6f8-6a03750d6ae4">948-2000</ix:nonNumeric></span></div></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant&#8217;s telephone number, including area code)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Former name or former address, if changed since last report)</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-top:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGV4dHJlZ2lvbjozZmQ5MTk0YzA3YTA0M2Q0ODM0MzI1NjZjZjliN2I3Yl8zOTk_905fb1a5-7193-4660-9018-612d4bf1b9ae">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-top:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGV4dHJlZ2lvbjozZmQ5MTk0YzA3YTA0M2Q0ODM0MzI1NjZjZjliN2I3Yl80OTE_73018133-f46b-4bef-b9d8-a94b01604ab5">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="margin-top:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGV4dHJlZ2lvbjozZmQ5MTk0YzA3YTA0M2Q0ODM0MzI1NjZjZjliN2I3Yl81ODQ_8a2ee54b-f104-4255-808d-0cd57c01b0e1">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d 2(b))</span></div><div style="margin-top:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGV4dHJlZ2lvbjozZmQ5MTk0YzA3YTA0M2Q0ODM0MzI1NjZjZjliN2I3Yl82OTM_ab64de90-3db0-425b-9fc4-026e3a6caa3e">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:31.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i381710d4910e422b97fea75cdcf8e78f_D20220428-20220428" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF8xLTAtMS0xLTc3MDMx_7758d42e-7801-4d01-b97c-ad3301c8f22a"><ix:nonNumeric contextRef="ief8d3a11266e481c983d30b0238d7b07_D20220428-20220428" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF8xLTAtMS0xLTc3MDMx_77cbb50b-92a5-45e2-bdfe-ba31b8f6af4d">Common Stock, $1.00 par value</ix:nonNumeric></ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ief8d3a11266e481c983d30b0238d7b07_D20220428-20220428" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF8xLTItMS0xLTc3MDMx_937937a4-0d17-4295-b954-cd14fc8717a1"><ix:nonNumeric contextRef="i381710d4910e422b97fea75cdcf8e78f_D20220428-20220428" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF8xLTItMS0xLTc3MDMx_9b9c1fb0-aa84-4a8e-a229-5f4c87f11c4f">BAX (NYSE)</ix:nonNumeric></ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ief8d3a11266e481c983d30b0238d7b07_D20220428-20220428" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF8xLTQtMS0xLTc3MDMx_e48a78f1-e2fc-4350-8064-8982e1acc447">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i381710d4910e422b97fea75cdcf8e78f_D20220428-20220428" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF8yLTQtMS0xLTc3MDMx_9bd0901f-476e-4c5e-b244-80308e326706">Chicago Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic7c6c94e8b81438ea60699f91e73e50f_D20220428-20220428" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF8zLTAtMS0xLTc3MDMx_a1302c46-6fce-4d7b-9303-40880778c09e">1.3% Global Notes due 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic7c6c94e8b81438ea60699f91e73e50f_D20220428-20220428" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF8zLTItMS0xLTc3MDMx_87c7edda-3c10-47e7-b2ce-4d49b3c5b7d8">BAX 25</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic7c6c94e8b81438ea60699f91e73e50f_D20220428-20220428" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF8zLTQtMS0xLTc3MDMx_4ff22a5a-0b80-4989-9979-79159425aa30">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if3990410f47145c99222032eee574cda_D20220428-20220428" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF80LTAtMS0xLTc3MDMx_a72bbbf1-d939-44ea-9140-31b15ad163f9">1.3% Global Notes due 2029</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if3990410f47145c99222032eee574cda_D20220428-20220428" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF80LTItMS0xLTc3MDMx_f4df5a67-a589-4f86-80eb-8a035ca2cf7b">BAX 29</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if3990410f47145c99222032eee574cda_D20220428-20220428" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF80LTQtMS0xLTc3MDMx_573b6f09-76b7-4b3a-9a85-d24b772f3730">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id93d7d4374c74218be5e80c4961e0172_D20220428-20220428" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF81LTAtMS0xLTc3MDMx_b17b5f86-985c-4772-81d5-06f52f8b8e04">0.4% Global Notes due 2024</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id93d7d4374c74218be5e80c4961e0172_D20220428-20220428" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF81LTItMS0xLTc3MDMx_0c615ea6-e4d4-4432-8285-d9b97a366a59">BAX 24</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id93d7d4374c74218be5e80c4961e0172_D20220428-20220428" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF81LTQtMS0xLTc3MDMx_3c55d133-b588-4831-bc51-8693c40ff89d">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="idde09224ed154ef6989119f50debc00a_D20220428-20220428" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF82LTAtMS0xLTc3MDMx_4f418cc7-88d0-48bf-9fa4-841e0443e351">3.95% Global Notes due 2030</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="idde09224ed154ef6989119f50debc00a_D20220428-20220428" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF82LTItMS0xLTc3MDMx_2ec9d9c9-ce59-47b8-b91b-2ce983e33e1c">BAX 30</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="idde09224ed154ef6989119f50debc00a_D20220428-20220428" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF82LTQtMS0xLTc3MDMx_eeb42846-98da-4d61-8bd9-e4a32d0c957a">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i73fcc3c461804f26a10565d678147c10_D20220428-20220428" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF83LTAtMS0xLTc3MDMx_6875d6e0-6239-48d7-a9d5-3882fae90469">1.73% Global Notes due 2031</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i73fcc3c461804f26a10565d678147c10_D20220428-20220428" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF83LTItMS0xLTc3MDMx_0df272f6-0f25-420b-9cef-9592618479ff">BAX 31</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i73fcc3c461804f26a10565d678147c10_D20220428-20220428" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF83LTQtMS0xLTc3MDMx_502ac4ad-dea4-4c0d-baab-a10d9d1e1a89">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter):</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGV4dHJlZ2lvbjozZmQ5MTk0YzA3YTA0M2Q0ODM0MzI1NjZjZjliN2I3Yl8xMTAy_6ae5528d-86a6-45b0-b419-7b86c7123fe2">&#9744;</ix:nonNumeric> Emerging growth company</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act: &#160;&#160;&#9744;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i24ea93e56c084a7189f356eebb530663_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item&#160;2.02 Results of Operations and Financial Condition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">On April&#160;28, 2022, Baxter International Inc. (the Company) issued an earnings press release for the period ended March&#160;31, 2022. The press release, including attachments, is furnished as Exhibit 99.1 to this report.</span></div><div style="margin-top:12pt"><span><br/></span></div><div id="i24ea93e56c084a7189f356eebb530663_10"></div><div style="-sec-extract:summary;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item&#160;9.01 Financial Statements and Exhibits.</span></div><div style="margin-top:10pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">Exhibits.</span></div><div style="margin-top:10pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:16.469%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.475%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit&#160;Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline" href="bax-20220331xex991.htm">Press Release Dated April 28, 2022</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i24ea93e56c084a7189f356eebb530663_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date: April&#160;28, 2022</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.597%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">BAXTER INTERNATIONAL INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">/s/ James K. Saccaro</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">James K. Saccaro</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Executive Vice President and</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>bax-20220331xex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i6f139ddfaa2442e18020e643323160e5_1"></div><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:right"><img alt="g782573page6aa01a.jpg" src="g782573page6aa01a.jpg" style="height:33px;margin-bottom:5pt;vertical-align:text-bottom;width:160px"></div></div><div style="margin-top:10pt;text-align:right"><font><br></font></div><div style="margin-top:10pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div><div style="margin-top:10pt;text-align:right"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">FOR IMMEDIATE RELEASE</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:12pt;font-weight:400;line-height:120%">BAXTER REPORTS FIRST-QUARTER 2022 RESULTS</font></div><div style="margin-top:10pt;text-align:center"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">First-quarter revenue of $3.7 billion increased 26% on a reported basis, 29% on a constant currency basis and 3% on an operational basis</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:7.8pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">1</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:10.8pt">First-quarter U.S. GAAP earnings per share (EPS) totaled $0.14&#59; Adjusted EPS totaled $0.93 </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:10.8pt">Baxter expects full-year 2022 sales growth of 23% to 24% on a reported basis, 25% to 26% on a constant currency basis and approximately 3% on an operational basis</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:10.8pt">Baxter expects full-year U.S. GAAP EPS of $2.35 to $2.43 and adjusted EPS of $4.12 to $4.20</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:10.8pt">The company is hosting an Investor Conference on May 25, 2022, to provide additional details regarding its strategic outlook and updated long-term financial guidance</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">DEERFIELD, Ill., APRIL 28, 2022 </font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">&#8211; Baxter International Inc. (NYSE&#58;BAX), a global medtech leader, today reported results for the first quarter of 2022.</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">&#8220;Our positive momentum in the first quarter of 2022 was fueled by the diversity and durability of our medically essential product portfolio &#8211; dynamics that have further strengthened with our recent acquisition of Hillrom,&#8221; said Jos&#233; (Joe) E. Almeida, chairman, president and chief executive officer. &#8220;As we continue to navigate the impact of COVID-19, geopolitical unrest, inflationary pressures and supply chain challenges, we remain focused on advancing our lifesaving Mission and enhancing shareholder value through innovation, increased global portfolio access and our steadfast focus on operational effectiveness. We look forward to sharing more information at our upcoming 2022 Investor Conference on how our strategy, long-range plan and trajectory will benefit our many stakeholder communities.&#8221;</font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%">______________________</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:115%">See tables to the press release for reconciliations of non-GAAP measures used in this press release to the corresponding U.S. GAAP measures.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:right"><img alt="g782573page6aa01a.jpg" src="g782573page6aa01a.jpg" style="height:33px;margin-bottom:5pt;vertical-align:text-bottom;width:160px"></div></div><div style="margin-top:6pt;text-indent:36pt"><font><br></font></div><div style="margin-top:6pt;text-indent:36pt"><font><br></font></div><div style="margin-top:6pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">First-Quarter Financial Results</font></div><div style="margin-bottom:6pt;text-indent:40.5pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Worldwide sales in the first quarter totaled approximately $3.7 billion, an increase of 26% on a reported basis, 29% on a constant currency basis and 3% on an operational basis. Operational sales in the quarter exclude the impacts of foreign exchange and the December 2021 acquisition of Hillrom.</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Sales in the U.S. totaled $1.76 billion, increasing 49% on a reported basis and 3% operationally. International sales of $1.95 billion increased 10% on a reported basis, 16% at constant currency and 3% operationally.</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Among Baxter&#8217;s businesses, Medication Delivery achieved double-digit growth at constant currency rates, driven by improving rates of hospital admissions and increased sales of large and small volume parenteral solutions as well as infusion systems. BioPharma Solutions also achieved double-digit constant-currency growth, reflecting the year-over-year impact of multiple collaborations to help manufacture COVID-19 vaccines on a contract basis. Advanced Surgery delivered high single-digit growth at constant currency rates, driven by an improvement in the rate of surgical procedures compared to the same period last year. Additionally, Renal Care and Clinical Nutrition grew at low single digits year-over-year at constant rates. Growth was partially offset by a decline in Pharmaceuticals, due to generic competition for certain molecules and supply constraints impacting product availability. Acute Therapies declined high single digits at constant currency rates, following last year&#8217;s surging demand for continuous renal replacement therapy (CRRT) products in the comparable period to help treat COVID-19.</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Baxter&#8217;s newly acquired Hillrom businesses &#8211; Patient Support Systems, Front Line Care and Surgical Solutions &#8211; contributed approximately $755 million to first-quarter performance on a reported basis.</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Please see the attached schedules accompanying this press release for additional details on sales performance in the quarter, including breakouts by Baxter&#8217;s product categories and segments.</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">For the first quarter, net income attributable to Baxter was $71 million, or $0.14 per diluted share, a decline of 76% on a U.S. GAAP (Generally Accepted Accounting Principles) basis. These results include special items totaling $400 million after tax, which were primarily related to intangible asset amortization and expenses related to the Hillrom acquisition. On an adjusted basis, </font></div><div><font><br></font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:right"><img alt="g782573page6aa01a.jpg" src="g782573page6aa01a.jpg" style="height:33px;margin-bottom:5pt;vertical-align:text-bottom;width:160px"></div></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">net income attributable to Baxter totaled $471 million, or $0.93 per diluted share, a 22% increase for the quarter. </font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Business Highlights</font><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:7.15pt;font-weight:400;line-height:174%;position:relative;top:-3.85pt;vertical-align:baseline">2</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Baxter continues to advance its strategic priorities in pursuit of its Mission to Save and Sustain Lives. Among recent highlights, the company&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%;padding-left:13.8pt">Announced a </font><font style="color:#0000ff;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%;text-decoration:underline">long-term strategic partnership with Digital Diagnostics</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> to offer its IDx-DR&#174; autonomous AI software as a diagnostic service combined with the </font><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Welch Allyn RetinaVue 700 Imager. </font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">The partnership is intended to improve access to effective diagnostic services for the detection of diabetic retinopathy, which frequently goes undiagnosed and untreated, potentially leading to higher risk of subsequent visual loss and blindness. </font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%;padding-left:13.8pt">Received U.S. FDA clearance of its </font><font style="color:#0000ff;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%;text-decoration:underline">ST Set used in continuous renal replacement therapy (CRRT)</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">. The ST Set is a pre-connected, disposable, extracorporeal (outside the body) circuit that provides blood purification through a semipermeable membrane to be used with the </font><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">PrisMax</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> or </font><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Prismaflex</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> control units (monitors). It has been available to customers in the U.S. since August 2020, when it received Emergency Use Authorization (EUA) from the FDA to provide CRRT to treat patients in an acute care environment during the COVID-19 pandemic.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%;padding-left:13.8pt">Announced </font><font style="color:#0000ff;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%;text-decoration:underline">data indicating that the use of its </font><font style="color:#0000ff;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%;text-decoration:underline">Sharesource</font><font style="color:#0000ff;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%;text-decoration:underline"> remote patient management platform</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> with an automated peritoneal dialysis (APD) cycler may improve the clinical effectiveness of home kidney patients' care by extending their time on therapy by 3.4 months.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%;padding-left:13.8pt">Announced findings from an </font><font style="color:#0000ff;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%;text-decoration:underline">observational study on data from the </font><font style="color:#0000ff;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%;text-decoration:underline">Starling</font><font style="color:#0000ff;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%;text-decoration:underline"> Registry</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> that found that monitoring changes in stroke volume and cardiac input may help predict mortality in critically ill patients. The study assessed 127 critical care patients in the intensive care unit that received hemodynamic monitoring using Baxter&#8217;s </font><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Starling</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> Fluid Management Monitoring System. </font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">__________________________</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:6.5pt;font-weight:400;line-height:174%;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:174%">See links to original press releases for additional product information.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:right"><img alt="g782573page6aa01a.jpg" src="g782573page6aa01a.jpg" style="height:33px;margin-bottom:5pt;vertical-align:text-bottom;width:160px"></div></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%;padding-left:11.4pt">Announced initial investments in </font><font style="color:#0000ff;font-family:'Franklin Gothic Book',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">nine startups participating in the mHUB Accelerator</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">, the largest and fastest-growing physical product innovation center in the U.S. Each of the nine startups is developing technologies that align with Baxter&#8217;s early-stage innovation priorities. </font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Among corporate responsibility highlights, Baxter was recently recognized by </font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:174%">Forbes</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> on its list of America&#8217;s Best Large Employers 2022, based on employee ratings of factors such as working conditions, development opportunities and compensation. Baxter was also recently named to </font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:174%">Forbes&#8217;</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> America's Best Employers for Diversity 2022, which identifies companies most dedicated to diversity, equity and inclusion.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Novum IQ Infusion Platform Update</font></div><div style="margin-bottom:6pt;text-indent:40.5pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">On March 21, 2022, and as shared in its </font><font style="color:#0000ff;font-family:'Franklin Gothic Book',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">Form 8-K</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">, Baxter submitted responses to FDA&#8217;s additional information requests for the company&#8217;s new </font><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Novum IQ</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:700;line-height:174%"> </font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Large Volume Pump (LVP) and related </font><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Dose IQ</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> Safety Software. On April 22, 2022, Baxter received an additional information request from FDA that identified an issue, the adequate resolution of which is required to obtain FDA clearance of the </font><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Novum IQ</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> LVP.  As a result, the 510(k) review has been placed on hold so that Baxter can respond accordingly. Baxter currently expects to respond to FDA&#8217;s additional information request within the calendar year. The company continues to expect submission of responses to FDA on the filing of the </font><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Novum IQ</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:700;line-height:174%"> </font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Syringe Pump in the second quarter of 2022.</font></div><div style="margin-bottom:6pt;text-indent:40.5pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">&#8220;We are committed to responding to the FDA&#8217;s requests, and to bringing the benefits of the </font><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Novum IQ</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> infusion platform to patients and caregivers in the U.S. and beyond,&#8221; said Almeida.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">2022 Financial Outlook</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">For full-year 2022&#58; Baxter now expects U.S. GAAP earnings of $2.35 to $2.43 per diluted share and adjusted earnings, before special items, of $4.12 to $4.20 per diluted share. The company expects sales growth of 23% to 24% on a reported basis, 25% to 26% on a constant currency basis and approximately 3% on an operational basis. Baxter&#8217;s updated full-year financial outlook reflects the impact from higher oil prices, ongoing supply chain challenges causing increased inflationary pressures as well as the removal of any contribution from the </font><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Novum IQ</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> infusion system.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:right"><img alt="g782573page6aa01a.jpg" src="g782573page6aa01a.jpg" style="height:33px;margin-bottom:5pt;vertical-align:text-bottom;width:160px"></div></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">For second-quarter 2022&#58; The company expects sales growth of approximately 26% on a reported basis, 29% to 30% on a constant currency basis and approximately 4% on an operational basis. </font></div><div style="margin-bottom:6pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">The company expects U.S. GAAP earnings of $0.48 to $0.51 per diluted share and adjusted earnings, before special items, of $0.86 to $0.89 per diluted share.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">2022 Investor Conference</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">On May 25, 2022, Baxter will host an Investor Conference in Glenview, Ill., with an accompanying live webcast. Chairman and CEO Joe Almeida and other members of Baxter&#8217;s senior leadership team will provide a closer look at the company&#8217;s growth strategy, innovation pipeline and long-range plan. More information including a </font><font style="color:#0000ff;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%;text-decoration:underline">link to register</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> for the conference is available in the </font><font style="color:#0000ff;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%;text-decoration:underline">Investor Relations section of Baxter.com</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">First-Quarter 2022 Earnings Conference Call</font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%">A webcast of Baxter&#8217;s first-quarter 2022 conference call for investors can be accessed live from a link on the company&#8217;s website at </font><font style="color:#0000ff;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%;text-decoration:underline">www.baxter.com</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> beginning at 7&#58;30 a.m. CDT on April 28, 2022. Please see </font><font style="color:#0000ff;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%;text-decoration:underline">www.baxter.com</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> for more information regarding this and future investor events and webcasts.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">About Baxter</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Every day, millions of patients, caregivers and healthcare providers rely on Baxter&#8217;s leading portfolio of diagnostic, critical care, kidney care, nutrition, hospital and surgical products used across patient homes, hospitals, physician offices and other sites of care. For 90 years, we&#8217;ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers who make it happen. With products, digital health solutions and therapies available in more than 100 countries, Baxter&#8217;s employees worldwide are now building upon the company&#8217;s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit </font><font style="color:#0000ff;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">www.baxter.com</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and follow us on </font><font style="color:#0000ff;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Twitter</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#0000ff;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">LinkedIn</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#0000ff;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Facebook</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Non-GAAP Financial Measures </font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This press release and the accompanying tables contain financial measures that are not calculated in accordance with U.S. GAAP. The non-GAAP financial measures include adjusted gross margin, adjusted selling, general and administrative expense, adjusted research and development expense, adjusted other operating income, net, adjusted operating income, adjusted operating margin, adjusted interest expense, net, adjusted income before income taxes, adjusted income tax expense, adjusted net income, adjusted net income attributable to Baxter stockholders, and adjusted diluted earnings per share, all of which exclude special items, sales growth on a constant currency and operational basis, and free cash flow. Special items are excluded because they are highly variable or unusual, and of a size that may substantially affect the company&#8217;s reported operations for a period. Certain of those items represent estimates based on information </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:right"><img alt="g782573page6aa01a.jpg" src="g782573page6aa01a.jpg" style="height:33px;margin-bottom:5pt;vertical-align:text-bottom;width:160px"></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:120%">reasonably available at the time of the press release. Future events or new information may result in different actual results.</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:9pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:9pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Net sales growth rates are presented on a constant currency basis. These measures provide information on the percentage change in net sales growth assuming that foreign currency exchange rates have not changed between the prior and current periods. Net sales growth rates are also presented on an operational basis. For the quarter ended March 31, 2022, operational sales growth excludes the impact of foreign exchange and the December 2021 acquisition of Hillrom. This measure provides information on the change in net sales growth rates assuming that foreign exchange rates remained constant and excluding the impact of the company&#8217;s recent acquisition of Hillrom.</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For the quarters ended March 31, 2022 and 2021, special items include intangible asset amortization, business optimization charges, acquisition and integration expenses, expenses related to European medical devices regulation, product-related items, and investigation and related costs. These items are excluded because they are highly variable or unusual and of a size that may substantially impact the company&#8217;s reported operations for a period. Additionally, intangible asset amortization is excluded as a special item to facilitate an evaluation of current and past operating performance and is consistent with how management and the company&#8217;s Board of Directors assess performance.</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Non-GAAP financial measures may enhance an understanding of the company&#8217;s operations and may facilitate an analysis of those operations, particularly in evaluating performance from one period to another. Management believes that non-GAAP financial measures, when used in conjunction with the results presented in accordance with U.S. GAAP and the reconciliations to corresponding U.S. GAAP financial measures, may enhance an investor&#8217;s overall understanding of the company&#8217;s past financial performance and prospects for the future. Accordingly, management uses these non-GAAP measures internally in financial planning, to monitor business unit performance, and, in some cases, for purposes of determining incentive compensation. This information should be considered in addition to, and not as substitutes for, information prepared in accordance with U.S. GAAP.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Forward-Looking Statements </font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">This release includes forward-looking statements concerning the company&#8217;s financial results (including the outlook for second-quarter and</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">full-year 2022) and business development and regulatory activities (including the December 2021 acquisition of Hillrom). These forward-looking statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements&#58; the impact of global economic conditions (including potential trade wars and economic sanctions) and public health crises and epidemics, such as the ongoing coronavirus (COVID-19) pandemic, on the company and its employees, customers and suppliers, including foreign governments in countries in which the company operates&#59; demand for and market acceptance of risks for new and existing products&#59; product development risks (including any delays in obtaining required regulatory approvals or failures to obtain such approvals)&#59; product quality or patient safety concerns&#59; continuity, availability and pricing of acceptable raw materials and component supply&#59; inability to create additional production capacity in a timely manner or the occurrence of other manufacturing or supply difficulties (including as a result of a natural disaster, public health crises and epidemics&#47;pandemics, geopolitical crises, regulatory actions or otherwise)&#59; accurate identification of and execution on </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:right"><img alt="g782573page6aa01a.jpg" src="g782573page6aa01a.jpg" style="height:33px;margin-bottom:5pt;vertical-align:text-bottom;width:160px"></div></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">business development and R&#38;D opportunities and realization of anticipated benefits (including the acquisitions of Cheetah Medical, </font><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Seprafilm Adhesion Barrier</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">, specified OUS </font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">rights to </font><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Caelyx&#47;Doxil</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">, full U.S. and specific OUS rights to </font><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Transderm Scop</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> PerClot</font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Hillrom and certain rights to Zosyn in the U.S. and Canada)&#59; breaches or failures of the company&#8217;s information technology systems or products, including by cyberattack, unauthorized access or theft&#59; the adequacy of the company&#8217;s cash flows from operations and other sources of liquidity to meet its ongoing cash obligations and fund its investment program&#59; loss of key employees or inability to identify and recruit new employees&#59; future actions of regulatory bodies and other governmental authorities, including FDA, the Department of Justice, the SEC, the New York Attorney General and foreign regulatory agencies, including the continued delay in lifting the warning letter at the company&#8217;s Ahmedabad facility&#59; the outcome of pending or future litigation, including the opioid litigation and current and future ethylene oxide litigation or other claims&#59; proposed regulatory changes of the U.S. Department of Health and Human Services in kidney health policy and reimbursement, which may substantially change the U.S. end-stage renal disease market and demand for the company&#8217;s peritoneal dialysis products, necessitating significant multiyear capital expenditures, which are difficult to estimate in advance&#59; failures with respect to compliance programs&#59; future actions of third parties, including payers&#59; U.S. healthcare reform and other global austerity measures&#59; pricing, reimbursement, taxation and rebate policies of government agencies and private payers&#59; the impact of competitive products and pricing, including generic competition, drug reimportation and disruptive technologies&#59; fluctuations in foreign exchange and interest rates&#59; the ability to enforce owned or in-licensed patents or the prevention or restriction of the manufacture, sale or use of products or technology affected by patents of third parties&#59; global, trade and tax policies&#59; any change in laws concerning the taxation of income (including current or future tax reform), including income earned outside the United States and potential taxes associated with the Base Erosion and Anti-Abuse Tax or the Build Back Better framework&#59; actions taken by tax authorities in connection with ongoing tax audits&#59; and other risks identified in Baxter&#8217;s most recent filings on Form 10-K and Form 10-Q and other SEC filings, all of which are available on Baxter&#8217;s website. Baxter does not undertake to update its forward-looking statements unless otherwise required by the federal securities laws.</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Baxter, Caelyx, Cheetah Medical, Dose IQ, Doxil, Hillrom, Novum IQ, Prismaflex, PrisMax, PerClot, RetinaVue, Seprafilm, Sharesource, Starling, and Welch Allyn are registered trademarks of Baxter International Inc. or its subsidiaries. IDx-DR is a registered trademark of Digital Diagnostics. Transderm Scop is a registered trademark of Novartis AG. Zosyn is a registered trademark of Pfizer Inc. Any other trademarks or product brands appearing herein are the property of their respective owners.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Media Contact</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Eric Tatro, (224) 948-5353</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:112%">media&#64;baxter.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Franklin Gothic Medium',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Investor Contact</font></div><div><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Clare Trachtman, (224) 948-3020</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:12pt;font-weight:400;line-height:115%">###</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:right"><img alt="g782573page6aa01a.jpg" src="g782573page6aa01a.jpg" style="height:33px;margin-bottom:5pt;vertical-align:text-bottom;width:160px"></div></div><div style="margin-bottom:6pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><div id="i6f139ddfaa2442e18020e643323160e5_4"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BAXTER &#8212; PAGE 8</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BAXTER INTERNATIONAL INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Income</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, except per share and percentage data)</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.821%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended <br>March 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">NET SALES</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,707</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,946&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">COST OF SALES</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,359</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,801&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">GROSS MARGIN</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,348</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,145&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">% of Net Sales</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">36.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">38.9&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(2.5&#160;pts)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SELLING, GENERAL AND ADMINISTRATIVE EXPENSES</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,052</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">627&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">% of Net Sales</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">28.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">21.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">7.1&#160;pts</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RESEARCH AND DEVELOPMENT EXPENSES</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">150</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">% of Net Sales</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">4.0</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">4.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(0.3&#160;pts)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">OTHER OPERATING INCOME, NET</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(17)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NM</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">OPERATING INCOME</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">163</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">390&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">% of Net Sales</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">4.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">13.2&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(8.8 pts)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">INTEREST EXPENSE, NET</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">85</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">OTHER (INCOME) EXPENSE, NET</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(16)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(420)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">INCOME BEFORE INCOME TAXES</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">94</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">351&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(73)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">INCOME TAX EXPENSE</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">% of Income Before Income Taxes</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">22.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">14.5&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">7.8&#160;pts</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">NET INCOME</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">73</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(76)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">NET INCOME ATTRIBUTABLE TO NONCONTROLLING INTERESTS</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">NET INCOME ATTRIBUTABLE TO BAXTER STOCKHOLDERS</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">71</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">298&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(76)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">EARNINGS PER SHARE</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Basic</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.59&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(76)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diluted</font></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.58&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(76)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">WEIGHTED-AVERAGE NUMBER OF SHARES OUTSTANDING</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Basic</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">503</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">505&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diluted</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">509</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">511&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ADJUSTED OPERATING INCOME (excluding special items)&#185;</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">666</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">501&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ADJUSTED INCOME BEFORE INCOME TAXES (excluding special items)&#185;</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">597</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">462&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ADJUSTED NET INCOME ATTRIBUTABLE TO BAXTER STOCKHOLDERS (excluding special items)&#185;</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">471</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">386&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ADJUSTED DILUTED EPS (excluding special items)&#185;</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.93</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.76&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Refer to page 9 for a description of the adjustments and a reconciliation to U.S. GAAP measures.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">NM - Not Meaningful </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i6f139ddfaa2442e18020e643323160e5_7"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BAXTER &#8212; PAGE 9</font></div></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BAXTER INTERNATIONAL INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description of Adjustments and Reconciliation of U.S. GAAP to&#160;Non-GAAP&#160;Measures</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited, in millions)</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The company&#8217;s U.S. GAAP results for the three months ended March&#160;31, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">included special items which impacted the U.S. GAAP measures as follows&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.824%"><tr><td style="width:1.0%"></td><td style="width:23.008%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.954%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.008%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.365%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Margin</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, General and Administrative Expenses</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and Development Expenses</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Operating Income, Net</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Income</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income Before Income Taxes</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income Tax Expense</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Income</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Income Attributable to Baxter Stockholders</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted Earnings Per Share</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,348</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,052</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">150</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(17)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">163</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">94</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">73</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">71</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported percent of net sales (or percent of income before income taxes for income tax expense)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.33&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business optimization items</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.12&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.28&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European medical devices regulation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">4</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product-related items</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">5</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,670</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">855</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">149</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">666</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">597</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">124</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">473</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">471</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.93</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted percent of net sales (or adjusted percent of income before income taxes for income tax expense)</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.0&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.8&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The company&#8217;s U.S. GAAP results for the three months ended March&#160;31, 2021</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">included special items which impacted the U.S. GAAP measures as follows&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.717%"><tr><td style="width:1.0%"></td><td style="width:22.817%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.748%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.857%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Margin</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, General and Administrative Expenses</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and Development Expenses</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Operating Income, Net</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Income</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income Before Income Taxes</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income Tax Expense</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Income</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Income Attributable to Baxter Stockholders</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted Earnings Per Share</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reported</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,145</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">627</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">128</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">390</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">351</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">51</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">300</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">298</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.58</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported percent of net sales (or percent of income before income taxes for income tax expense)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset amortization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business optimization items</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">3</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European medical devices regulation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">4</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investigation and related costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">6</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.02&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,238</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">609</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">128</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">501</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">462</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">74</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">388</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">386</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.76</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted percent of net sales (or adjusted percent of income before income taxes for income tax expense)</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.0&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.75pt">The company&#8217;s results in 2022 and 2021 included intangible asset amortization expense of $217 million ($169 million, or $0.33 per diluted share, on an&#160;after-tax&#160;basis) and $64 million ($52 million, or $0.10 per diluted share, on an&#160;after-tax&#160;basis), respectively.</font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.75pt">The company&#8217;s results in 2022 and 2021 included charges of $81 million ($61 million, or $0.12 per diluted share, on an&#160;after-tax&#160;basis) and $27 million ($20 million, or $0.04 per diluted share, on an&#160;after-tax&#160;basis), respectively, associated with its programs to optimize its organization and cost structure on a global basis. In 2022, restructuring charges include actions taken in connection with our integration of Hill-Rom Holdings, Inc. (Hillrom), which we acquired in December 2021.</font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.75pt">The company&#8217;s results in 2022 included $171 million ($141 million, or $0.28 per diluted share, on an&#160;after-tax&#160;basis) of acquisition and integration-related expenses. That amount includes costs related to our acquisition of Hillrom, primarily reflecting incremental costs of sales from the fair value step-ups on acquired Hillrom inventory that was sold in the current period. The acquisition and integration-related expenses related to Hillrom were partially offset by a benefit from a change in the estimated fair value of contingent consideration liabilities assumed in the Hillrom acquisition. The company&#8217;s results in 2021 included $1 million ($1 million, or $0.00 per diluted share, on an after-tax basis) of integration expenses related to the acquisition of the rights to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Caelyx</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Doxil</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for specified territories outside of the U.S.</font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.75pt">The company&#8217;s results in 2022 and 2021 included costs of $11 million ($9 million, or $0.02 per diluted share, on an&#160;after-tax&#160;basis) and $8 million ($6 million, or $0.01 per diluted share, on an after-tax basis) related to updating its quality systems and product labeling to comply with the new medical device reporting regulation and other requirements of the European Union&#8217;s regulations for medical devices that became effective in stages beginning in 2021.</font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.75pt">The company's results in 2022 included charges of $23 million ($20 million, or $0.04 per diluted share, on an after-tax basis) related to warranty and remediation activities from two field corrective actions on certain of our infusion pumps.</font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.75pt">The company&#8217;s results in 2021 included costs of $11 million ($9 million, or $0.02 per diluted share, on an after-tax basis) for investigation and related costs from matters associated with the company&#8217;s investigation of foreign exchange gains and losses. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information on the company's use of non-GAAP financial measures, please see the Non-GAAP Financial Measures section of this press release.   </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i6f139ddfaa2442e18020e643323160e5_16"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BAXTER &#8212; PAGE 10</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">BAXTER INTERNATIONAL INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Sales by Operating Segment</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(unaudited)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">($ in millions)</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.807%"><tr><td style="width:1.0%"></td><td style="width:47.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.801%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.801%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.858%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.859%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;Growth&#160;&#64;<br>Actual Rates</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;Growth&#160;&#64;<br>Constant&#160;Rates</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Americas</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,626&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,560&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">EMEA</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">699&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">738&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">APAC</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">627&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">648&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hillrom</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">755&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Baxter</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,707</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,946</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">26</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">29</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Constant currency growth is a&#160;non-GAAP&#160;measure. For more information on the company&#8217;s use of&#160;non-GAAP&#160;financial measures, please see the Non-GAAP Financial Measures section of this press release.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i6f139ddfaa2442e18020e643323160e5_19"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BAXTER &#8212; PAGE 11</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">BAXTER INTERNATIONAL INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Sales by Product Category</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(unaudited)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">($ in millions)</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;Growth&#160;&#64;<br>Actual Rates</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;Growth&#160;&#64;<br>Constant&#160;Rates</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renal Care&#160;&#185;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medication Delivery&#160;&#178;</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmaceuticals&#160;&#179;</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Nutrition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">4</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Surgery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">5</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acute Therapies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">6</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BioPharma Solutions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">7</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patient Support Systems </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">8</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Line Care </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">9</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgical Solutions </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">10</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">11</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Baxter</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,707</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,946</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:18pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.75pt">Includes sales of the company&#8217;s peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services.</font></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.75pt">Includes sales of the company&#8217;s intravenous (IV)&#160;therapies, infusion pumps, administration sets and drug reconstitution devices.</font></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.75pt">Includes sales of the company&#8217;s premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services.</font></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.75pt">Includes sales of the company&#8217;s parenteral nutrition (PN) therapies and related products.</font></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.75pt">Includes sales of the company&#8217;s biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention.</font></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.75pt">Includes sales of the company&#8217;s continuous renal replacement therapies (CRRT) and other organ support therapies focused in the intensive care unit (ICU).</font></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.75pt">Includes sales of contracted services the company provides to various pharmaceutical and biopharmaceutical companies.</font></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.75pt">Includes sales of connected care solutions&#58; devices, software, communications and integration technologies.</font></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.75pt">Includes sales of integrated patient monitoring and diagnostic technologies to help diagnose, treat and manage a wide variety of illness and diseases, including respiratory therapy, cardiology, vision screening and physical assessment.</font></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">Includes sales of surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. </font></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.5pt">Includes sales of other miscellaneous product and service offerings.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Constant currency growth is a&#160;non-GAAP&#160;measure. For more information on the company&#8217;s use of&#160;non-GAAP&#160;financial measures, please see the Non-GAAP Financial Measures section of this press release.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i6f139ddfaa2442e18020e643323160e5_22"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BAXTER &#8212; PAGE 12</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">BAXTER INTERNATIONAL INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Product Category Sales by U.S. and International</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(unaudited)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">($ in millions)</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Growth</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Renal Care</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">669&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">894&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">216&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">706&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">922&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medication Delivery</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">472&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">706&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">411&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">241&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">652&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceuticals</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">364&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">521&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">352&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">552&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clinical Nutrition</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">227&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Advanced Surgery</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">136&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">228&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acute Therapies</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">207&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">BioPharma Solutions</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient Support Systems</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">295&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">383&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N&#47;A</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Front Line Care</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">207&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">294&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N&#47;A</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Surgical Solutions</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N&#47;A</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Baxter</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,757</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,950</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,707</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,180</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,766</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,946</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">49</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">26</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i6f139ddfaa2442e18020e643323160e5_28"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BAXTER &#8212; PAGE 13</font></div></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BAXTER INTERNATIONAL INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reconciliation of&#160;Non-GAAP&#160;Financial Measure</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Cash Flow to Free Cash Flow</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">($ in millions)</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.883%"><tr><td style="width:1.0%"></td><td style="width:71.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.460%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows from operations &#8211; continuing operations</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">208&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">377&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows from investing activities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(304)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(538)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows from financing activities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(548)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(358)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows from operations - continuing operations</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">208&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">377&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capital expenditures</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(140)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(171)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Free cash flow - continuing operations</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">68</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">206</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Free cash flow is a&#160;non-GAAP&#160;measure. For more information on the company&#8217;s use of&#160;non-GAAP&#160;financial measures, please see the Non-GAAP Financial Measures section of this press release.</font></div><div style="margin-top:12pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i6f139ddfaa2442e18020e643323160e5_31"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BAXTER &#8212; PAGE 14</font></div></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BAXTER INTERNATIONAL INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reconciliation of&#160;Non-GAAP&#160;Financial Measure</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Change in Net Sales Growth As Reported to Operational Sales Growth</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">From The Three Months Ended March 31, 2021 to The Three Months Ended March 31, 2022</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Sales Growth<br>As&#160;Reported</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Hillrom</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">FX</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operational<br>Sales Growth*</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Renal Care</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medication Delivery</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pharmaceuticals</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clinical Nutrition</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Advanced Surgery</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acute Therapies</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">BioPharma Solutions</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient Support Systems</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Front Line Care</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Surgical Solutions</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Baxter</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(26)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(46)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">International</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*Totals may not add across due to rounding</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operational sales growth is a&#160;non-GAAP&#160;measure. For more information on the company&#8217;s use of&#160;non-GAAP&#160;financial measures, please see the Non-GAAP Financial Measures section of this press release.</font></div><div style="margin-top:9pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i6f139ddfaa2442e18020e643323160e5_37"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BAXTER &#8212; PAGE 15</font></div></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BAXTER INTERNATIONAL INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reconciliation of&#160;Non-GAAP&#160;Financial Measures</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Projected Second Quarter and Full Year 2022 U.S. GAAP Sales Growth to Projected Operational Sales Growth, and Projected Second Quarter and Full Year 2022 U.S. GAAP Earnings Per Share to Projected Adjusted Earnings Per Share</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.275%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Sales Growth Guidance</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Q2 2022*</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">FY 2022*</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Sales Growth - U.S. GAAP</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26%</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23% - 24%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hillrom</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25)% - (26)%</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22)% - (23)%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3% - 4%</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Sales Growth - Operational</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4%</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3%</font></td></tr></table></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Totals may not foot due to rounding</font></div><div style="margin-top:9pt;text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.275%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earnings Per Share Guidance</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Q2 2022*</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">FY 2022*</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earnings per Diluted Share - U.S. GAAP</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$0.48 - $0.51</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$2.35 - $2.43</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Estimated intangible asset amortization</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.29</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$1.11</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Estimated business optimization charges</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.02</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.16</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Estimated acquisition and integration expenses</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.05</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.39</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Estimated product-related items</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.00</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.04</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Estimated European medical devices regulation</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.02</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0.07</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earnings per Diluted Share - Adjusted</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$0.86 - $0.89</font></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$4.12 - $4.20</font></td></tr></table></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">*</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Totals may not foot due to rounding</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The company&#8217;s outlook for U.S. GAAP earnings per share only includes the impact of special items that are known or expected as of the date of this release. Accordingly, actual U.S. GAAP earnings per share for the second quarter and full year of 2022 may differ significantly from those amounts. For example, the company&#8217;s outlook does not reflect the potential impact of future business or asset acquisitions or dispositions, intangible asset impairments, restructuring actions, developments related to gain or loss contingencies, or unusual or infrequently occurring items that may occur during the remainder of 2022.</font></div><div style="margin-top:9pt;text-align:center"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>bax-20220428.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:b58d54f6-cdfc-4a1b-bd93-899aabf6e1c3,g:5b5b1c76-46ea-4a42-acb6-696751fef255-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bax="http://www.baxter.com/20220428" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.baxter.com/20220428">
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bax-20220428_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bax-20220428_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bax-20220428_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformationDocument" roleURI="http://www.baxter.com/role/DocumentandEntityInformationDocument">
        <link:definition>0001001 - Document - Document and Entity Information Document</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="bax_CommonStock1.00PerValueMember" abstract="true" name="CommonStock1.00PerValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_GlobalNotes04Due2024Member" abstract="true" name="GlobalNotes04Due2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_GlobalNotes13Due2025Member" abstract="true" name="GlobalNotes13Due2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_GlobalNotes173Due2031Member" abstract="true" name="GlobalNotes173Due2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_GlobalNotes395Due2030Member" abstract="true" name="GlobalNotes395Due2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bax_GlobalNotes13Due2029Member" abstract="true" name="GlobalNotes13Due2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>bax-20220428_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:b58d54f6-cdfc-4a1b-bd93-899aabf6e1c3,g:5b5b1c76-46ea-4a42-acb6-696751fef255-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.baxter.com/role/DocumentandEntityInformationDocument" xlink:type="simple" xlink:href="bax-20220428.xsd#DocumentandEntityInformationDocument"/>
  <link:definitionLink xlink:role="http://www.baxter.com/role/DocumentandEntityInformationDocument" xlink:type="extended" id="i540f30c75e3e41e4986ac62505626cfc_DocumentandEntityInformationDocument">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_4d75451f-9ab5-4a22-b92b-e16b446a63be" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_DocumentType_4d75451f-9ab5-4a22-b92b-e16b446a63be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_2d1c6e05-f1ac-4721-a613-7a50e5986c52" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_DocumentPeriodEndDate_2d1c6e05-f1ac-4721-a613-7a50e5986c52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_d9ed279a-89ad-4fd6-b630-51fd368d6a83" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_EntityRegistrantName_d9ed279a-89ad-4fd6-b630-51fd368d6a83" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_058fbded-44cb-4d8a-8a10-3939a3072bd6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_EntityCentralIndexKey_058fbded-44cb-4d8a-8a10-3939a3072bd6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_796158a9-914c-4b52-ad00-5c712799430e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_AmendmentFlag_796158a9-914c-4b52-ad00-5c712799430e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_77995510-f212-44b4-900c-f2263b1198d7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_EntityIncorporationStateCountryCode_77995510-f212-44b4-900c-f2263b1198d7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_d579dc00-2bce-4baa-a511-e7fbea459cca" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_EntityFileNumber_d579dc00-2bce-4baa-a511-e7fbea459cca" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_b9806077-1257-421c-ae88-7b285779178b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_EntityTaxIdentificationNumber_b9806077-1257-421c-ae88-7b285779178b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_57adeb8f-7973-41af-8324-302ed9aa991b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_EntityAddressAddressLine1_57adeb8f-7973-41af-8324-302ed9aa991b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_4ef801c6-170f-439f-a06c-d11bc58710f5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_EntityAddressCityOrTown_4ef801c6-170f-439f-a06c-d11bc58710f5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_af83dd10-faf3-4d82-b0d1-e9a433705fb2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_EntityAddressStateOrProvince_af83dd10-faf3-4d82-b0d1-e9a433705fb2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_834624ea-507f-4e4a-9177-84de075235f9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_EntityAddressPostalZipCode_834624ea-507f-4e4a-9177-84de075235f9" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_03c41b07-1c38-4aea-b541-15299a336a5e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_CityAreaCode_03c41b07-1c38-4aea-b541-15299a336a5e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_17740758-93a9-4a18-97ab-289d285cdeeb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_LocalPhoneNumber_17740758-93a9-4a18-97ab-289d285cdeeb" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_259135bb-5400-4afb-90e5-3eeb026d1cd5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_WrittenCommunications_259135bb-5400-4afb-90e5-3eeb026d1cd5" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_cbbcdebd-5f02-4bd8-b02c-958fa470a34f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_SolicitingMaterial_cbbcdebd-5f02-4bd8-b02c-958fa470a34f" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_0b55197d-ab0c-474a-94f3-55c1c7c3a93c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_PreCommencementTenderOffer_0b55197d-ab0c-474a-94f3-55c1c7c3a93c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_4f49aef4-0dfe-4b2d-bf28-0dc22a79fe20" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_4f49aef4-0dfe-4b2d-bf28-0dc22a79fe20" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_cc8fedf4-d51e-401f-aa5c-2ad3f0b82a5c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_EntityEmergingGrowthCompany_cc8fedf4-d51e-401f-aa5c-2ad3f0b82a5c" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_3ed27a26-c4c3-46b1-85dc-d5d220a7d61a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_Security12bTitle_3ed27a26-c4c3-46b1-85dc-d5d220a7d61a" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_beb924ae-c2d0-447a-a677-e45138dcb750" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_TradingSymbol_beb924ae-c2d0-447a-a677-e45138dcb750" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_fd76f690-5b2d-42b2-bea8-81382d5b095d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_SecurityExchangeName_fd76f690-5b2d-42b2-bea8-81382d5b095d" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_b104a690-d966-4c7f-bad2-e64c308d4d01" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_EntitiesTable_b104a690-d966-4c7f-bad2-e64c308d4d01" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_6cf774e1-dc35-4813-964d-c2504d8118e9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsExchangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_b104a690-d966-4c7f-bad2-e64c308d4d01" xlink:to="loc_dei_EntityListingsExchangeAxis_6cf774e1-dc35-4813-964d-c2504d8118e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_6cf774e1-dc35-4813-964d-c2504d8118e9_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityListingsExchangeAxis_6cf774e1-dc35-4813-964d-c2504d8118e9" xlink:to="loc_dei_ExchangeDomain_6cf774e1-dc35-4813-964d-c2504d8118e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_d70de5ec-b084-4087-94b5-82c49714fc4d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityListingsExchangeAxis_6cf774e1-dc35-4813-964d-c2504d8118e9" xlink:to="loc_dei_ExchangeDomain_d70de5ec-b084-4087-94b5-82c49714fc4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS_db6795bc-2340-4f8b-9400-5dd3055cf179" xlink:href="https://xbrl.sec.gov/exch/2021/exch-2021.xsd#exch_XNYS"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain_d70de5ec-b084-4087-94b5-82c49714fc4d" xlink:to="loc_exch_XNYS_db6795bc-2340-4f8b-9400-5dd3055cf179" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XCHI_0f674b33-913f-42e7-88c9-e5485043bcff" xlink:href="https://xbrl.sec.gov/exch/2021/exch-2021.xsd#exch_XCHI"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain_d70de5ec-b084-4087-94b5-82c49714fc4d" xlink:to="loc_exch_XCHI_0f674b33-913f-42e7-88c9-e5485043bcff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_291d7241-a91c-4969-a633-d3208535e3a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_b104a690-d966-4c7f-bad2-e64c308d4d01" xlink:to="loc_us-gaap_StatementClassOfStockAxis_291d7241-a91c-4969-a633-d3208535e3a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_291d7241-a91c-4969-a633-d3208535e3a5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_291d7241-a91c-4969-a633-d3208535e3a5" xlink:to="loc_us-gaap_ClassOfStockDomain_291d7241-a91c-4969-a633-d3208535e3a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_fe067d0d-9d07-4a5e-9a79-0e6d97ae8cd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_291d7241-a91c-4969-a633-d3208535e3a5" xlink:to="loc_us-gaap_ClassOfStockDomain_fe067d0d-9d07-4a5e-9a79-0e6d97ae8cd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_CommonStock1.00PerValueMember_2779bb8a-5d59-487d-b7fc-78c1cf82fbb3" xlink:href="bax-20220428.xsd#bax_CommonStock1.00PerValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_fe067d0d-9d07-4a5e-9a79-0e6d97ae8cd5" xlink:to="loc_bax_CommonStock1.00PerValueMember_2779bb8a-5d59-487d-b7fc-78c1cf82fbb3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes13Due2025Member_3ac29e90-0785-45c0-82c9-97b38c95dbf6" xlink:href="bax-20220428.xsd#bax_GlobalNotes13Due2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_fe067d0d-9d07-4a5e-9a79-0e6d97ae8cd5" xlink:to="loc_bax_GlobalNotes13Due2025Member_3ac29e90-0785-45c0-82c9-97b38c95dbf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes13Due2029Member_82321391-b2d6-403b-b950-489f747d7821" xlink:href="bax-20220428.xsd#bax_GlobalNotes13Due2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_fe067d0d-9d07-4a5e-9a79-0e6d97ae8cd5" xlink:to="loc_bax_GlobalNotes13Due2029Member_82321391-b2d6-403b-b950-489f747d7821" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes04Due2024Member_4849a4b4-0f0b-4af7-8ff2-4f1a488a365b" xlink:href="bax-20220428.xsd#bax_GlobalNotes04Due2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_fe067d0d-9d07-4a5e-9a79-0e6d97ae8cd5" xlink:to="loc_bax_GlobalNotes04Due2024Member_4849a4b4-0f0b-4af7-8ff2-4f1a488a365b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes395Due2030Member_1fe4f08a-cb93-4ab2-b86e-6eca7731109f" xlink:href="bax-20220428.xsd#bax_GlobalNotes395Due2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_fe067d0d-9d07-4a5e-9a79-0e6d97ae8cd5" xlink:to="loc_bax_GlobalNotes395Due2030Member_1fe4f08a-cb93-4ab2-b86e-6eca7731109f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes173Due2031Member_e8060f30-128a-4342-8982-603157699014" xlink:href="bax-20220428.xsd#bax_GlobalNotes173Due2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_fe067d0d-9d07-4a5e-9a79-0e6d97ae8cd5" xlink:to="loc_bax_GlobalNotes173Due2031Member_e8060f30-128a-4342-8982-603157699014" xlink:type="arc" order="5"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>bax-20220428_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:b58d54f6-cdfc-4a1b-bd93-899aabf6e1c3,g:5b5b1c76-46ea-4a42-acb6-696751fef255-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_exch_XCHI_d77b8056-1a79-43d0-aee0-7c023947843e_terseLabel_en-US" xlink:label="lab_exch_XCHI" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CHICAGO STOCK EXCHANGE, INC</link:label>
    <link:label id="lab_exch_XCHI_label_en-US" xlink:label="lab_exch_XCHI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CHICAGO STOCK EXCHANGE, INC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XCHI" xlink:href="https://xbrl.sec.gov/exch/2021/exch-2021.xsd#exch_XCHI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exch_XCHI" xlink:to="lab_exch_XCHI" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_2cc9fd01-bc0f-4602-a35b-edc4dbff3e69_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_b98f7642-d278-478a-893c-d479425fcd62_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_81eb4c7d-8975-4a45-8ca5-1d0720d3868f_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_b9d893aa-e57e-4b86-8b51-4cfd166e194c_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_7905e98c-28d7-412a-b7ce-5f5de9df917d_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_f92bead6-9a44-461f-89f5-22ea3d2b08e3_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_a9cc6fb0-acd7-4e1f-805a-75d4bfcbe286_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_GlobalNotes395Due2030Member_1d627008-3889-433a-af13-5e9fba62a446_terseLabel_en-US" xlink:label="lab_bax_GlobalNotes395Due2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Notes 3.95% due 2030</link:label>
    <link:label id="lab_bax_GlobalNotes395Due2030Member_label_en-US" xlink:label="lab_bax_GlobalNotes395Due2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Notes 3.95% due 2030 [Member]</link:label>
    <link:label id="lab_bax_GlobalNotes395Due2030Member_documentation_en-US" xlink:label="lab_bax_GlobalNotes395Due2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Notes 3.95% due 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes395Due2030Member" xlink:href="bax-20220428.xsd#bax_GlobalNotes395Due2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_GlobalNotes395Due2030Member" xlink:to="lab_bax_GlobalNotes395Due2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_GlobalNotes04Due2024Member_ab7cf663-d71c-4370-b1e1-4bb22730b7fb_terseLabel_en-US" xlink:label="lab_bax_GlobalNotes04Due2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.4% Global Notes due 2024</link:label>
    <link:label id="lab_bax_GlobalNotes04Due2024Member_label_en-US" xlink:label="lab_bax_GlobalNotes04Due2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Notes 0.4% due 2024 [Member]</link:label>
    <link:label id="lab_bax_GlobalNotes04Due2024Member_documentation_en-US" xlink:label="lab_bax_GlobalNotes04Due2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.4% Global Notes due 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes04Due2024Member" xlink:href="bax-20220428.xsd#bax_GlobalNotes04Due2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_GlobalNotes04Due2024Member" xlink:to="lab_bax_GlobalNotes04Due2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_58b497b9-ad52-4e39-baae-ee2071e21133_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_fdb64583-1db7-4915-bb6c-924d959298ce_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityListingsExchangeAxis_71064af4-875e-4851-9d95-567d0306caf8_terseLabel_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:label id="lab_dei_EntityListingsExchangeAxis_label_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsExchangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityListingsExchangeAxis" xlink:to="lab_dei_EntityListingsExchangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_f142276b-7614-4ba8-9f96-f97133ebf3d5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_f73bf5ed-7462-4bbb-aa11-a9d57c8eef92_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_GlobalNotes13Due2025Member_20a8ff80-845e-4e4c-9552-dd9cba814068_terseLabel_en-US" xlink:label="lab_bax_GlobalNotes13Due2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.3% Global Notes due 2025</link:label>
    <link:label id="lab_bax_GlobalNotes13Due2025Member_label_en-US" xlink:label="lab_bax_GlobalNotes13Due2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Notes 1.3% due 2025 [Member]</link:label>
    <link:label id="lab_bax_GlobalNotes13Due2025Member_documentation_en-US" xlink:label="lab_bax_GlobalNotes13Due2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.3% Global Notes due 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes13Due2025Member" xlink:href="bax-20220428.xsd#bax_GlobalNotes13Due2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_GlobalNotes13Due2025Member" xlink:to="lab_bax_GlobalNotes13Due2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_424a8b3f-29f4-40d6-9791-704e832556bd_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_3274fb63-2a2f-4cae-9e0b-127c17db1707_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_GlobalNotes173Due2031Member_a52a3297-4736-46b7-ba54-34f00210f807_terseLabel_en-US" xlink:label="lab_bax_GlobalNotes173Due2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Notes 1.73% due 2031</link:label>
    <link:label id="lab_bax_GlobalNotes173Due2031Member_label_en-US" xlink:label="lab_bax_GlobalNotes173Due2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Notes 1.73% due 2031 [Member]</link:label>
    <link:label id="lab_bax_GlobalNotes173Due2031Member_documentation_en-US" xlink:label="lab_bax_GlobalNotes173Due2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Notes 1.73% due 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes173Due2031Member" xlink:href="bax-20220428.xsd#bax_GlobalNotes173Due2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_GlobalNotes173Due2031Member" xlink:to="lab_bax_GlobalNotes173Due2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_696c9f27-c8cb-45b1-bc1f-037ad7483e99_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_8553a5c8-e72c-4a42-b6ea-9a7d4044093b_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_CommonStock1.00PerValueMember_b2bd3b39-1e7d-481a-a0c6-7e9399357bfa_terseLabel_en-US" xlink:label="lab_bax_CommonStock1.00PerValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, $1.00 Per Value</link:label>
    <link:label id="lab_bax_CommonStock1.00PerValueMember_label_en-US" xlink:label="lab_bax_CommonStock1.00PerValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, $1.00 Per Value [Member]</link:label>
    <link:label id="lab_bax_CommonStock1.00PerValueMember_documentation_en-US" xlink:label="lab_bax_CommonStock1.00PerValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, $1.00 Per Value [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_CommonStock1.00PerValueMember" xlink:href="bax-20220428.xsd#bax_CommonStock1.00PerValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_CommonStock1.00PerValueMember" xlink:to="lab_bax_CommonStock1.00PerValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_27595506-1732-438f-80a0-737330ad80b7_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_ExchangeDomain_c92b510b-6a1b-40fd-b2d1-0ee40d1b3318_terseLabel_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:label id="lab_dei_ExchangeDomain_label_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_ExchangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ExchangeDomain" xlink:to="lab_dei_ExchangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bax_GlobalNotes13Due2029Member_0dbd9cb1-57cc-4528-924e-7adf000e25bd_terseLabel_en-US" xlink:label="lab_bax_GlobalNotes13Due2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.3% Global Notes due 2029</link:label>
    <link:label id="lab_bax_GlobalNotes13Due2029Member_label_en-US" xlink:label="lab_bax_GlobalNotes13Due2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global Notes 1.3% due 2029 [Member]</link:label>
    <link:label id="lab_bax_GlobalNotes13Due2029Member_documentation_en-US" xlink:label="lab_bax_GlobalNotes13Due2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.3% Global Notes due 2029 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes13Due2029Member" xlink:href="bax-20220428.xsd#bax_GlobalNotes13Due2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bax_GlobalNotes13Due2029Member" xlink:to="lab_bax_GlobalNotes13Due2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_3c757111-fd44-4b40-ae24-a89df341e88f_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_b5b861dd-8420-4890-aede-c35fe3e5bcd1_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_exch_XNYS_14177ff2-074f-4b77-95c3-54b055124a45_terseLabel_en-US" xlink:label="lab_exch_XNYS" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW YORK STOCK EXCHANGE, INC.</link:label>
    <link:label id="lab_exch_XNYS_label_en-US" xlink:label="lab_exch_XNYS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW YORK STOCK EXCHANGE, INC. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS" xlink:href="https://xbrl.sec.gov/exch/2021/exch-2021.xsd#exch_XNYS"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exch_XNYS" xlink:to="lab_exch_XNYS" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_059afbef-801e-4f07-997e-95fde295f20a_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_f9a0e037-d75b-4686-b05f-f26491dbc871_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_979e2ef5-a4f9-47f5-81a0-2750541410c4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_a896c0bf-f283-4844-96fb-8f3777be7f83_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_c22d035e-9dc6-4e7d-98d5-98f6443fba22_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_6f5dfff4-08a5-4fb6-bed8-9edebc6b15c0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_9891b783-1a72-4d64-b980-0224d43dfd2a_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_736ec137-a2fe-4b1f-89af-dc7db2f51a56_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_b413a876-482e-42a9-ae95-587d7e7a7a44_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>bax-20220428_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:b58d54f6-cdfc-4a1b-bd93-899aabf6e1c3,g:5b5b1c76-46ea-4a42-acb6-696751fef255-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.baxter.com/role/DocumentandEntityInformationDocument" xlink:type="simple" xlink:href="bax-20220428.xsd#DocumentandEntityInformationDocument"/>
  <link:presentationLink xlink:role="http://www.baxter.com/role/DocumentandEntityInformationDocument" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_1183f12f-00e7-4424-957b-94faead866e1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_b104a690-d966-4c7f-bad2-e64c308d4d01" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1183f12f-00e7-4424-957b-94faead866e1" xlink:to="loc_dei_EntitiesTable_b104a690-d966-4c7f-bad2-e64c308d4d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_6cf774e1-dc35-4813-964d-c2504d8118e9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsExchangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_b104a690-d966-4c7f-bad2-e64c308d4d01" xlink:to="loc_dei_EntityListingsExchangeAxis_6cf774e1-dc35-4813-964d-c2504d8118e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_d70de5ec-b084-4087-94b5-82c49714fc4d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_ExchangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityListingsExchangeAxis_6cf774e1-dc35-4813-964d-c2504d8118e9" xlink:to="loc_dei_ExchangeDomain_d70de5ec-b084-4087-94b5-82c49714fc4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS_db6795bc-2340-4f8b-9400-5dd3055cf179" xlink:href="https://xbrl.sec.gov/exch/2021/exch-2021.xsd#exch_XNYS"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_ExchangeDomain_d70de5ec-b084-4087-94b5-82c49714fc4d" xlink:to="loc_exch_XNYS_db6795bc-2340-4f8b-9400-5dd3055cf179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XCHI_0f674b33-913f-42e7-88c9-e5485043bcff" xlink:href="https://xbrl.sec.gov/exch/2021/exch-2021.xsd#exch_XCHI"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_ExchangeDomain_d70de5ec-b084-4087-94b5-82c49714fc4d" xlink:to="loc_exch_XCHI_0f674b33-913f-42e7-88c9-e5485043bcff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_291d7241-a91c-4969-a633-d3208535e3a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_b104a690-d966-4c7f-bad2-e64c308d4d01" xlink:to="loc_us-gaap_StatementClassOfStockAxis_291d7241-a91c-4969-a633-d3208535e3a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_fe067d0d-9d07-4a5e-9a79-0e6d97ae8cd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_291d7241-a91c-4969-a633-d3208535e3a5" xlink:to="loc_us-gaap_ClassOfStockDomain_fe067d0d-9d07-4a5e-9a79-0e6d97ae8cd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_CommonStock1.00PerValueMember_2779bb8a-5d59-487d-b7fc-78c1cf82fbb3" xlink:href="bax-20220428.xsd#bax_CommonStock1.00PerValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_fe067d0d-9d07-4a5e-9a79-0e6d97ae8cd5" xlink:to="loc_bax_CommonStock1.00PerValueMember_2779bb8a-5d59-487d-b7fc-78c1cf82fbb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes13Due2025Member_3ac29e90-0785-45c0-82c9-97b38c95dbf6" xlink:href="bax-20220428.xsd#bax_GlobalNotes13Due2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_fe067d0d-9d07-4a5e-9a79-0e6d97ae8cd5" xlink:to="loc_bax_GlobalNotes13Due2025Member_3ac29e90-0785-45c0-82c9-97b38c95dbf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes13Due2029Member_82321391-b2d6-403b-b950-489f747d7821" xlink:href="bax-20220428.xsd#bax_GlobalNotes13Due2029Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_fe067d0d-9d07-4a5e-9a79-0e6d97ae8cd5" xlink:to="loc_bax_GlobalNotes13Due2029Member_82321391-b2d6-403b-b950-489f747d7821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes04Due2024Member_4849a4b4-0f0b-4af7-8ff2-4f1a488a365b" xlink:href="bax-20220428.xsd#bax_GlobalNotes04Due2024Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_fe067d0d-9d07-4a5e-9a79-0e6d97ae8cd5" xlink:to="loc_bax_GlobalNotes04Due2024Member_4849a4b4-0f0b-4af7-8ff2-4f1a488a365b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes395Due2030Member_1fe4f08a-cb93-4ab2-b86e-6eca7731109f" xlink:href="bax-20220428.xsd#bax_GlobalNotes395Due2030Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_fe067d0d-9d07-4a5e-9a79-0e6d97ae8cd5" xlink:to="loc_bax_GlobalNotes395Due2030Member_1fe4f08a-cb93-4ab2-b86e-6eca7731109f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bax_GlobalNotes173Due2031Member_e8060f30-128a-4342-8982-603157699014" xlink:href="bax-20220428.xsd#bax_GlobalNotes173Due2031Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_fe067d0d-9d07-4a5e-9a79-0e6d97ae8cd5" xlink:to="loc_bax_GlobalNotes173Due2031Member_e8060f30-128a-4342-8982-603157699014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_b104a690-d966-4c7f-bad2-e64c308d4d01" xlink:to="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_4d75451f-9ab5-4a22-b92b-e16b446a63be" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_DocumentType_4d75451f-9ab5-4a22-b92b-e16b446a63be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_2d1c6e05-f1ac-4721-a613-7a50e5986c52" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_DocumentPeriodEndDate_2d1c6e05-f1ac-4721-a613-7a50e5986c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_d9ed279a-89ad-4fd6-b630-51fd368d6a83" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_EntityRegistrantName_d9ed279a-89ad-4fd6-b630-51fd368d6a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_058fbded-44cb-4d8a-8a10-3939a3072bd6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_EntityCentralIndexKey_058fbded-44cb-4d8a-8a10-3939a3072bd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_796158a9-914c-4b52-ad00-5c712799430e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_AmendmentFlag_796158a9-914c-4b52-ad00-5c712799430e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_77995510-f212-44b4-900c-f2263b1198d7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_EntityIncorporationStateCountryCode_77995510-f212-44b4-900c-f2263b1198d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_d579dc00-2bce-4baa-a511-e7fbea459cca" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_EntityFileNumber_d579dc00-2bce-4baa-a511-e7fbea459cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_b9806077-1257-421c-ae88-7b285779178b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_EntityTaxIdentificationNumber_b9806077-1257-421c-ae88-7b285779178b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_57adeb8f-7973-41af-8324-302ed9aa991b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_EntityAddressAddressLine1_57adeb8f-7973-41af-8324-302ed9aa991b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_4ef801c6-170f-439f-a06c-d11bc58710f5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_EntityAddressCityOrTown_4ef801c6-170f-439f-a06c-d11bc58710f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_af83dd10-faf3-4d82-b0d1-e9a433705fb2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_EntityAddressStateOrProvince_af83dd10-faf3-4d82-b0d1-e9a433705fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_834624ea-507f-4e4a-9177-84de075235f9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_EntityAddressPostalZipCode_834624ea-507f-4e4a-9177-84de075235f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_03c41b07-1c38-4aea-b541-15299a336a5e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_CityAreaCode_03c41b07-1c38-4aea-b541-15299a336a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_17740758-93a9-4a18-97ab-289d285cdeeb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_LocalPhoneNumber_17740758-93a9-4a18-97ab-289d285cdeeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_259135bb-5400-4afb-90e5-3eeb026d1cd5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_WrittenCommunications_259135bb-5400-4afb-90e5-3eeb026d1cd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_cbbcdebd-5f02-4bd8-b02c-958fa470a34f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_SolicitingMaterial_cbbcdebd-5f02-4bd8-b02c-958fa470a34f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_0b55197d-ab0c-474a-94f3-55c1c7c3a93c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_PreCommencementTenderOffer_0b55197d-ab0c-474a-94f3-55c1c7c3a93c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_4f49aef4-0dfe-4b2d-bf28-0dc22a79fe20" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_4f49aef4-0dfe-4b2d-bf28-0dc22a79fe20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_cc8fedf4-d51e-401f-aa5c-2ad3f0b82a5c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_EntityEmergingGrowthCompany_cc8fedf4-d51e-401f-aa5c-2ad3f0b82a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_3ed27a26-c4c3-46b1-85dc-d5d220a7d61a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_Security12bTitle_3ed27a26-c4c3-46b1-85dc-d5d220a7d61a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_beb924ae-c2d0-447a-a677-e45138dcb750" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_TradingSymbol_beb924ae-c2d0-447a-a677-e45138dcb750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_fd76f690-5b2d-42b2-bea8-81382d5b095d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_64fa4961-bd47-4727-8c52-6ff4873051c2" xlink:to="loc_dei_SecurityExchangeName_fd76f690-5b2d-42b2-bea8-81382d5b095d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g782573page6aa01a.jpg
<TEXT>
begin 644 g782573page6aa01a.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1  (! @0$ P0'!00$  $"=P ! @,1
M! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H
M*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&
MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76
MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_  !$( "( H0,!$0 "$0$#$0'_V@ ,
M P$  A$#$0 _ /?Z /)=:^,-SI>N7UA!I<$\5M,T2R&4C=@X]*]6G@%."DWN
M>94QSA-Q2V*2_&S46&5T*$CVE;_"K_LZ/\Q']H2_E$/QNOP<'1( ?^NS?X4_
M[-C_ #!_:$OY3T;P9XLA\7Z,;U(#;RQ/Y<L9.0&P#P>XP:\[$4'0GRG?0K*M
M'F.BKG-PH * "@ H * (+N\MM/M7N;R>.""/[TDC!57G')JHQ<G:*%*2BKLQ
M7\=^%HVVG7+1FR!A'W9^F.M;?5JW\K,?K%+^8Z&N<W"@ H * "@ H * "@"E
MK&H)I6C7NH.0%MX6DY[D#@5=.'/-1[D3ER1<NQ\HR2/+(\CG+N2S'U)ZU]2E
M96/F6[NY[!X!\:^%O#?A.WLKN^9+MG:28"!SAB>F0.> *\G%8:M5J.26AZN&
MQ%&E346]3S'Q'J8UOQ+J&HQJ0EQ,S(,<[>@_' %>E1A[.FHOH>=5G[2HY(]8
M\,:3XDT+X:Q#1+,#5[Z?SF$NT>6G;(;V4<?[5>56G2J5_??NH]2C"I3H>XM6
M-W_%W_GG:?\ D'_&C_8OZN+_ &S^K&%KWC/XA^&9X8=5EMH9)E+(%CC?(!QV
MK>EA\-55X?J8U<1B*3M+]#IOAM\0;_Q+?S:7JD<;3I&98YHUVY (!!'3N.:Y
ML9A8THJ<-CHPF*E5?+(R_'GBWQAX3U\P17D;6,X\RW=K=2<=U)QU'^%:X6A0
MK0NUJMS/$UZU&=D]!W@'XFW^IZZ=/U^XB*3K^YD"! KCG!QZC^5&*P<80YJ:
MV##8N4Y\M0O>)/B5<W>H)HO@V$WEZ7PTX3<O'4*.X]6/%9T<&HQYZ^B+JXMM
M\E'5F1\0[K7[#P;:V6O:C'/>7\P9HH8U58T09(R.2<E?;BML)&G*JY4UHC+%
M2J1I)3>K/._#NFZEJNMV\&DPK+>(?-17("_+SSGBO0JSA"#<]C@I0E.:4-SV
M71I_B)!JD<_B%K:'285:2X91&3M"D]N>M>/46%<;4]^FYZ]-XE2O4V^1Q&I?
M&#Q%<7LCV!@M+7)\M#$';';)/?Z5VPP%)+WM6<4\=4;]W1&P==^* T+^VBL
ML?)\_<4BSLQG.WKTYK'V6$Y^3K\S;VF*Y.?I\C'TWXP^(K:\C>_\B[MLC>GE
MA&QWP1W^M;3P%)KW=&8PQU1/WM4;_P 0?B'K&B>(TL]'ND2#[.CNKQ*V&;)[
M^V*PPN$A4I\TT;XG%3ISM!F/IWQ&\=:I:S0V%J;R=6!,L5KN\M?3 &.?>M9X
M3#P=Y.WS,H8JO-6BK_(ZOP-K?C74_$;V^O1/;VD4!D*R6OEEB3@8./K^5<N)
MIX>%.]/?U.G#U*\IVJ;>AZ37G'H' ?%_5/L/@W[(K8DO9ECQ_LCYC_(#\:[\
M!#FJW['#CI\M*W<\*TVR?4M4M+&+[]Q*L0_$XKVYR4(N3Z'C0CS244>O^+_A
M[X5\/^$[_48H)A/%'B(F=C\Y( X^IKR</BZU6HHMGJU\+2ITW*QXS&\D4J/"
MS+(I!1E."#VQ7L-)JS/(6CT/0OB+XMUK^TX='6^DA6UMXQ<"%BGF2E06)(^O
M2N#"4*?+SVWV]#OQ5>?-R7V(?!'A35O&-M=W!UZYM(8'" [F?<V,G^(8P,?G
M3Q->%!I<MQ8>C.LF^:QS?BO3WTGQ'<Z:^H27YML(9I,@YP"1R3TS730GSTU*
MUKG-7CR3<;WL>A_!'3/GU356' "VZ'_QYO\ V6O/S&?PP^9WY?#>1U/Q2@TB
M?PA*NI7*03H=]H3RQD'8#J0>A_.N7!.:J^ZM.ITXQ0=/WGZ'SS7T!X)] ?"<
M:-)X42;3K98KQ3Y=VQ.7+COGT(Y Z5X&.]HJEI/3H>[@N3V=XK7J>?\ Q@U,
MWOC(6:GY+*%4Q_M-\Q_0C\J]# 0Y:5^YPXZ=ZENQL?!+3-]YJ>JLO$:+ A]S
MRW\E_.L<QG91@:Y?#5S.W^)>I_V9X$U J</< 6Z_\"//Z9KBP<.>LO+4[,7/
MDI,^=[&RGU&^@LK9-\\[B-%SC))Q7T$I*$7)]#P8Q<I**/5[K1/BC>:2^ES2
MVILWC\HHIC7Y>F,@9KRHU,'&7.M_F>HZ>*<>5[?(P;#X2>)/[1MOMEO EKYJ
M^:PG!(3//'TKHECJ7*^5ZF$<%4YE?8Y7Q1J7]K^*-2OE.4EG;R_]P<+^@%=-
M"')343FK3YZCD>U_"/3?L/@B.X9</>2M+^ ^4?\ H/ZUXV/GS5K=CU\%#EI7
M[G>5PG:% 'FGQ'\(>(O%FJ6OV%+<65K&0IDFP69NIQCV KTL)7I4(OFW9Y^*
MH5*TER[(X^V^%'C&SN([BVDMH9HSE)$N"&4^H.*ZWCJ$E9_D<BP5:+NBW??#
MWX@ZG"(;_4EN8@=P26\9AGUP141Q>&@[Q5OD7+"XB2M)_B2^'?A#J\6N6L^K
M/;)9P.)&6-][/@Y"]*57'P<&H;CI8&:FG/8T_'7POU'6=?EU72)H6^TX,L4S
M%2K 8R#CD<5GAL;&G#DGT-,3@Y3GSP*>B^#OB/H%JUIIE_:6T#OO9=ZL,\#/
M*GT%54Q&%J.\DV33H8FFK1=C+OOA-XMN=0N)Y)K6X>21F,K2X+DGKC'&:UCC
MJ*BDM#*6"K.3;/0/#FBZ]X5\#1Z?8V5M+JID=F,DV(P2>&SC)XQQ^M<%:I3K
M5N:3T.ZE3J4:7+%:F+IGPTU+6-9?5?&E\+EP?E@B<D$>A/&%]A6T\9"G#DH*
MQE#"2G+FK.Y1\8_"B]O=>:Z\/Q6T5I*@+1,VP(_0X '3H?SK3#XZ,86J;F=?
M!.4[T]BSX#\%^*_"6O">5;9K&<;+A%FR<=F QU!_F:G$XBC6A9;K8K#8>K1G
M=[">//ACJ>M^(9=6TJ:%A<!?,CE8J58 #(..1@"C#8R%.')/H&)P<JD^>/4J
MZ%X1^(_AJWEM]+NK*&&1M[(SJXW8QGE?:JJU\+5=YIDTZ&)I*T6;UWX/\2>)
MO"-S9>(=2B.I?:%EMRH'EH%7&#M ZY;]*PCB*5*JI4UI8VE0JU:;C4>IQ=C\
M+?&6F7\-[9O9QW$#[HW$V<$>Q%=DL;0G'EE>QR1P=:#NCJ_LOQ9_Z"&G_DG_
M ,37+S8+LSJY<7W1>L;'XAM:Z@=4O;660V[1VT49509&XW,0O11DX]:B4L-=
M<BZZEQCB+/F9Y]_PI_Q4!]VS_P"__P#]:N_Z_1\S@^HU3W'0[#^R]!L+':%-
MO D; '(R ,_K7BU)<\W+N>S3CR04>Q?K,L* "@ H * "@ H * "@ H * "@
5H * "@ H * "@ H * "@ H * /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139903890190424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information Document<br></strong></div></th>
<th class="th"><div>Apr. 28, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr. 28,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Baxter International Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000010456<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-4448<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">36-0781620<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One Baxter Parkway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Deerfield<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">60015<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">224<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">948-2000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingsExchangeAxis=exch_XNYS', window );">NEW YORK STOCK EXCHANGE, INC. | Common Stock, $1.00 Per Value</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $1.00 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAX (NYSE)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingsExchangeAxis=exch_XNYS', window );">NEW YORK STOCK EXCHANGE, INC. | 1.3% Global Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.3% Global Notes due 2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAX 25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingsExchangeAxis=exch_XNYS', window );">NEW YORK STOCK EXCHANGE, INC. | 1.3% Global Notes due 2029</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.3% Global Notes due 2029<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAX 29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingsExchangeAxis=exch_XNYS', window );">NEW YORK STOCK EXCHANGE, INC. | 0.4% Global Notes due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.4% Global Notes due 2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAX 24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingsExchangeAxis=exch_XNYS', window );">NEW YORK STOCK EXCHANGE, INC. | Global Notes 3.95% due 2030</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">3.95% Global Notes due 2030<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAX 30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingsExchangeAxis=exch_XNYS', window );">NEW YORK STOCK EXCHANGE, INC. | Global Notes 1.73% due 2031</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.73% Global Notes due 2031<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAX 31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingsExchangeAxis=exch_XCHI', window );">CHICAGO STOCK EXCHANGE, INC | Common Stock, $1.00 Per Value</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $1.00 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAX (NYSE)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">CHX<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=exch_XNYS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=exch_XNYS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bax_CommonStock1.00PerValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bax_CommonStock1.00PerValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes13Due2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bax_GlobalNotes13Due2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes13Due2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bax_GlobalNotes13Due2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes04Due2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bax_GlobalNotes04Due2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes395Due2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bax_GlobalNotes395Due2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bax_GlobalNotes173Due2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bax_GlobalNotes173Due2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=exch_XCHI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=exch_XCHI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>bax-20220428_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bax="http://www.baxter.com/20220428"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:exch="http://xbrl.sec.gov/exch/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bax-20220428.xsd" xlink:type="simple"/>
    <context id="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
        </entity>
        <period>
            <startDate>2022-04-28</startDate>
            <endDate>2022-04-28</endDate>
        </period>
    </context>
    <context id="i381710d4910e422b97fea75cdcf8e78f_D20220428-20220428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:CommonStock1.00PerValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XCHI</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-28</startDate>
            <endDate>2022-04-28</endDate>
        </period>
    </context>
    <context id="ief8d3a11266e481c983d30b0238d7b07_D20220428-20220428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:CommonStock1.00PerValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-28</startDate>
            <endDate>2022-04-28</endDate>
        </period>
    </context>
    <context id="ic7c6c94e8b81438ea60699f91e73e50f_D20220428-20220428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes13Due2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-28</startDate>
            <endDate>2022-04-28</endDate>
        </period>
    </context>
    <context id="if3990410f47145c99222032eee574cda_D20220428-20220428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes13Due2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-28</startDate>
            <endDate>2022-04-28</endDate>
        </period>
    </context>
    <context id="id93d7d4374c74218be5e80c4961e0172_D20220428-20220428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes04Due2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-28</startDate>
            <endDate>2022-04-28</endDate>
        </period>
    </context>
    <context id="idde09224ed154ef6989119f50debc00a_D20220428-20220428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes395Due2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-28</startDate>
            <endDate>2022-04-28</endDate>
        </period>
    </context>
    <context id="i73fcc3c461804f26a10565d678147c10_D20220428-20220428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000010456</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bax:GlobalNotes173Due2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-28</startDate>
            <endDate>2022-04-28</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M180L2ZyYWc6ZjBmNDkwYjA3Y2MwNDMwNGIyMDI5MzYyOTBhYTAwMTMvdGFibGU6NTllNzE5ZWI2ZDg0NGM0M2FjMDEyZWRkMDc0OTdlNjMvdGFibGVyYW5nZTo1OWU3MTllYjZkODQ0YzQzYWMwMTJlZGQwNzQ5N2U2M18yLTEtMS0xLTc3MDMx_82bfd8f7-e90a-499c-b58c-528b1ff48378">0000010456</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M180L2ZyYWc6ZjBmNDkwYjA3Y2MwNDMwNGIyMDI5MzYyOTBhYTAwMTMvdGFibGU6NTllNzE5ZWI2ZDg0NGM0M2FjMDEyZWRkMDc0OTdlNjMvdGFibGVyYW5nZTo1OWU3MTllYjZkODQ0YzQzYWMwMTJlZGQwNzQ5N2U2M18zLTEtMS0xLTc3MDMx_f5dc4a14-1ede-4b57-b389-fb8490a07823">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGV4dHJlZ2lvbjozZmQ5MTk0YzA3YTA0M2Q0ODM0MzI1NjZjZjliN2I3Yl84Mg_6c7b031d-2615-44cc-ae40-f294b2b6786d">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGV4dHJlZ2lvbjozZmQ5MTk0YzA3YTA0M2Q0ODM0MzI1NjZjZjliN2I3Yl8yMjM_25de28fa-7457-4580-95e4-56adceed9c0a">2022-04-28</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6NjMyMWU3NTYzMTIzNGEwMGJmYTNjOGZjMWViYTc5YjcvdGFibGVyYW5nZTo2MzIxZTc1NjMxMjM0YTAwYmZhM2M4ZmMxZWJhNzliN18wLTAtMS0xLTc3MDMx_d14818dc-882c-4377-b826-5e4e56142dcf">Baxter International Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6NjMyMWU3NTYzMTIzNGEwMGJmYTNjOGZjMWViYTc5YjcvdGFibGVyYW5nZTo2MzIxZTc1NjMxMjM0YTAwYmZhM2M4ZmMxZWJhNzliN18zLTAtMS0xLTc3MDMx_d72221a5-220c-4f38-bd1c-f3ee3f3b348c">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6NjMyMWU3NTYzMTIzNGEwMGJmYTNjOGZjMWViYTc5YjcvdGFibGVyYW5nZTo2MzIxZTc1NjMxMjM0YTAwYmZhM2M4ZmMxZWJhNzliN182LTAtMS0xLTc3MDMx_3cc12792-f9b8-47d1-8daa-74511976307d">1-4448</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6NjMyMWU3NTYzMTIzNGEwMGJmYTNjOGZjMWViYTc5YjcvdGFibGVyYW5nZTo2MzIxZTc1NjMxMjM0YTAwYmZhM2M4ZmMxZWJhNzliN182LTEtMS0xLTc3MDMx_904ad2a7-e604-4b86-b6ea-f0053de1e83c">36-0781620</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6NjMyMWU3NTYzMTIzNGEwMGJmYTNjOGZjMWViYTc5YjcvdGFibGVyYW5nZTo2MzIxZTc1NjMxMjM0YTAwYmZhM2M4ZmMxZWJhNzliN185LTAtMS0xLTc3MDMxL3RleHRyZWdpb246YzBjYTA5NGQ1ODUyNDJkMWE4ZjBmM2FiZTQ4MjU4MmNfNA_9ed31d9a-e5c0-4008-a254-4466da892217">One Baxter Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6NjMyMWU3NTYzMTIzNGEwMGJmYTNjOGZjMWViYTc5YjcvdGFibGVyYW5nZTo2MzIxZTc1NjMxMjM0YTAwYmZhM2M4ZmMxZWJhNzliN185LTAtMS0xLTc3MDMxL3RleHRyZWdpb246YzBjYTA5NGQ1ODUyNDJkMWE4ZjBmM2FiZTQ4MjU4MmNfOA_7889c42e-5860-4f77-adfc-721a1bd06126">Deerfield</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6NjMyMWU3NTYzMTIzNGEwMGJmYTNjOGZjMWViYTc5YjcvdGFibGVyYW5nZTo2MzIxZTc1NjMxMjM0YTAwYmZhM2M4ZmMxZWJhNzliN185LTAtMS0xLTc3MDMxL3RleHRyZWdpb246YzBjYTA5NGQ1ODUyNDJkMWE4ZjBmM2FiZTQ4MjU4MmNfMTI_379c2e88-b2a7-44f1-b188-bb8ed994e9de">IL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6NjMyMWU3NTYzMTIzNGEwMGJmYTNjOGZjMWViYTc5YjcvdGFibGVyYW5nZTo2MzIxZTc1NjMxMjM0YTAwYmZhM2M4ZmMxZWJhNzliN185LTEtMS0xLTc3MDMx_ec201de6-ea63-4108-8443-594ab5ecc9bc">60015</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6NjMyMWU3NTYzMTIzNGEwMGJmYTNjOGZjMWViYTc5YjcvdGFibGVyYW5nZTo2MzIxZTc1NjMxMjM0YTAwYmZhM2M4ZmMxZWJhNzliN18xMi0wLTEtMS03NzAzMS90ZXh0cmVnaW9uOjA5N2RkZDEzMzBlNzRlOWM5ZDM4OGFlNmI4MGYzOTk2XzU_3fe583b4-f1cc-49de-ba85-4ad7e69848f7">224</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6NjMyMWU3NTYzMTIzNGEwMGJmYTNjOGZjMWViYTc5YjcvdGFibGVyYW5nZTo2MzIxZTc1NjMxMjM0YTAwYmZhM2M4ZmMxZWJhNzliN18xMi0wLTEtMS03NzAzMS90ZXh0cmVnaW9uOjA5N2RkZDEzMzBlNzRlOWM5ZDM4OGFlNmI4MGYzOTk2Xzg_2677c541-e354-4038-a6f8-6a03750d6ae4">948-2000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGV4dHJlZ2lvbjozZmQ5MTk0YzA3YTA0M2Q0ODM0MzI1NjZjZjliN2I3Yl8zOTk_905fb1a5-7193-4660-9018-612d4bf1b9ae">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGV4dHJlZ2lvbjozZmQ5MTk0YzA3YTA0M2Q0ODM0MzI1NjZjZjliN2I3Yl80OTE_73018133-f46b-4bef-b9d8-a94b01604ab5">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGV4dHJlZ2lvbjozZmQ5MTk0YzA3YTA0M2Q0ODM0MzI1NjZjZjliN2I3Yl81ODQ_8a2ee54b-f104-4255-808d-0cd57c01b0e1">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGV4dHJlZ2lvbjozZmQ5MTk0YzA3YTA0M2Q0ODM0MzI1NjZjZjliN2I3Yl82OTM_ab64de90-3db0-425b-9fc4-026e3a6caa3e">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i381710d4910e422b97fea75cdcf8e78f_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF8xLTAtMS0xLTc3MDMx_7758d42e-7801-4d01-b97c-ad3301c8f22a">Common Stock, $1.00 par value</dei:Security12bTitle>
    <dei:Security12bTitle
      contextRef="ief8d3a11266e481c983d30b0238d7b07_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF8xLTAtMS0xLTc3MDMx_77cbb50b-92a5-45e2-bdfe-ba31b8f6af4d">Common Stock, $1.00 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ief8d3a11266e481c983d30b0238d7b07_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF8xLTItMS0xLTc3MDMx_937937a4-0d17-4295-b954-cd14fc8717a1">BAX (NYSE)</dei:TradingSymbol>
    <dei:TradingSymbol
      contextRef="i381710d4910e422b97fea75cdcf8e78f_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF8xLTItMS0xLTc3MDMx_9b9c1fb0-aa84-4a8e-a229-5f4c87f11c4f">BAX (NYSE)</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ief8d3a11266e481c983d30b0238d7b07_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF8xLTQtMS0xLTc3MDMx_e48a78f1-e2fc-4350-8064-8982e1acc447">NYSE</dei:SecurityExchangeName>
    <dei:SecurityExchangeName
      contextRef="i381710d4910e422b97fea75cdcf8e78f_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF8yLTQtMS0xLTc3MDMx_9bd0901f-476e-4c5e-b244-80308e326706">CHX</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ic7c6c94e8b81438ea60699f91e73e50f_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF8zLTAtMS0xLTc3MDMx_a1302c46-6fce-4d7b-9303-40880778c09e">1.3% Global Notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ic7c6c94e8b81438ea60699f91e73e50f_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF8zLTItMS0xLTc3MDMx_87c7edda-3c10-47e7-b2ce-4d49b3c5b7d8">BAX 25</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ic7c6c94e8b81438ea60699f91e73e50f_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF8zLTQtMS0xLTc3MDMx_4ff22a5a-0b80-4989-9979-79159425aa30">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="if3990410f47145c99222032eee574cda_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF80LTAtMS0xLTc3MDMx_a72bbbf1-d939-44ea-9140-31b15ad163f9">1.3% Global Notes due 2029</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="if3990410f47145c99222032eee574cda_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF80LTItMS0xLTc3MDMx_f4df5a67-a589-4f86-80eb-8a035ca2cf7b">BAX 29</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="if3990410f47145c99222032eee574cda_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF80LTQtMS0xLTc3MDMx_573b6f09-76b7-4b3a-9a85-d24b772f3730">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="id93d7d4374c74218be5e80c4961e0172_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF81LTAtMS0xLTc3MDMx_b17b5f86-985c-4772-81d5-06f52f8b8e04">0.4% Global Notes due 2024</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="id93d7d4374c74218be5e80c4961e0172_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF81LTItMS0xLTc3MDMx_0c615ea6-e4d4-4432-8285-d9b97a366a59">BAX 24</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="id93d7d4374c74218be5e80c4961e0172_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF81LTQtMS0xLTc3MDMx_3c55d133-b588-4831-bc51-8693c40ff89d">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="idde09224ed154ef6989119f50debc00a_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF82LTAtMS0xLTc3MDMx_4f418cc7-88d0-48bf-9fa4-841e0443e351">3.95% Global Notes due 2030</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="idde09224ed154ef6989119f50debc00a_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF82LTItMS0xLTc3MDMx_2ec9d9c9-ce59-47b8-b91b-2ce983e33e1c">BAX 30</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="idde09224ed154ef6989119f50debc00a_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF82LTQtMS0xLTc3MDMx_eeb42846-98da-4d61-8bd9-e4a32d0c957a">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i73fcc3c461804f26a10565d678147c10_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF83LTAtMS0xLTc3MDMx_6875d6e0-6239-48d7-a9d5-3882fae90469">1.73% Global Notes due 2031</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i73fcc3c461804f26a10565d678147c10_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF83LTItMS0xLTc3MDMx_0df272f6-0f25-420b-9cef-9592618479ff">BAX 31</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i73fcc3c461804f26a10565d678147c10_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGFibGU6MDkyOWVmZGY3ZDg2NDY3MzkyNzIyODRkMWQ0YjM5ODgvdGFibGVyYW5nZTowOTI5ZWZkZjdkODY0NjczOTI3MjI4NGQxZDRiMzk4OF83LTQtMS0xLTc3MDMx_502ac4ad-dea4-4c0d-baab-a10d9d1e1a89">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0ZWE5M2U1NmMwODRhNzE4OWYzNTZlZWJiNTMwNjYzL3NlYzoyNGVhOTNlNTZjMDg0YTcxODlmMzU2ZWViYjUzMDY2M18xL2ZyYWc6M2ZkOTE5NGMwN2EwNDNkNDgzNDMyNTY2Y2Y5YjdiN2IvdGV4dHJlZ2lvbjozZmQ5MTk0YzA3YTA0M2Q0ODM0MzI1NjZjZjliN2I3Yl8xMTAy_6ae5528d-86a6-45b0-b419-7b86c7123fe2">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M1S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ =SJ<5)>*NQS
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M=1,92L88!.R '<(Y_<Z[5ITPX1X=\G>A^[<#K3P&]'@!6^A<JU3'\TLDO,3
MQFU+BLX5>C(,=D",Y1]XVXG\-/O4(VSV'T:$%'J6"V&%E+C?Z/F-:#R!+ ]=
MR_$)'0.M#,,SQ;;!<.AHQ$5V9://8:Q#B'/Z3XRQJK"$52Q;#X&'' E<)S"D
M&IND53 >"CVN*!.L>@PL(:EU&*ADMW,JI]=V<,TB]RI#FJ,,:&T'X:-:"Q4&
ML&]R( DNR94;4EWI>::W=Y-[2:AU[D&P]_ :C1W-CQ^W_ %02P,$%     @
M=SJ<5"0>FZ*M    ^ $  !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L
M<[61/0Z#, R%KQ+E #50J4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>+7_O
MR4Z?:!1W;J"V\R1&:P;*9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!
MV#-DGNZ9HIP\_D-T==UI?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6
MHJ@R&8HJEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0
M   ( '<ZG%1ED'F2&0$  ,\#   3    6T-O;G1E;G1?5'EP97-=+GAM;*V3
M34[#,!"%KQ)E6R4N+%B@IAM@"UUP 6-/&JO^DV=:TMLS3MI*H!(5A4VL>-Z\
MSYZ7K-Z/$;#HG?78E!U1?!0"50=.8ATB>*ZT(3E)_)JV(DJUDUL0]\OE@U#!
M$WBJ*'N4Z]4SM')OJ7CI>1M-\$V9P&)9/(W"S&I*&:,U2A+7Q<'K'Y3J1*BY
M<]!@9R(N6%"*JX1<^1UPZGL[0$I&0[&1B5ZE8Y7HK4 Z6L!ZVN+*&4/;&@4Z
MJ+WCEAIC JFQ R!GZ]%T,4TFGC",S[O9_,%F"LC*30H1.;$$?\>=(\G=560C
M2&2FKW@ALO7L^T%.6X.^D<WC_0QI-^2!8ECFS_A[QA?_&\[Q$<+NOS^QO-9.
M&G_FB^$_7G\!4$L! A0#%     @ =SJ<5 =!36*!    L0   !
M     ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " !W.IQ4'H/O
M]NX    K @  $0              @ &O    9&]C4')O<',O8V]R92YX;6Q0
M2P$"% ,4    " !W.IQ4F5R<(Q &  "<)P  $P              @ ', 0
M>&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( '<ZG%2?",8]V 4  $HA
M   8              " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q0
M2P$"% ,4    " !W.IQ4GZ ;\+$"  #B#   #0              @ $;#@
M>&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( '<ZG%27BKL<P    !,"   +
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4!08     "0 ) #X"  ![%0     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>8</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>8</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="bax-20220428.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Document and Entity Information Document</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.baxter.com/role/DocumentandEntityInformationDocument</Role>
      <ShortName>Document and Entity Information Document</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="bax-20220428.htm">bax-20220428.htm</File>
    <File>bax-20220331xex991.htm</File>
    <File>bax-20220428.xsd</File>
    <File>bax-20220428_def.xml</File>
    <File>bax-20220428_lab.xml</File>
    <File>bax-20220428_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="40">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "bax-20220428.htm": {
   "axisCustom": 0,
   "axisStandard": 2,
   "contextCount": 8,
   "dts": {
    "definitionLink": {
     "local": [
      "bax-20220428_def.xml"
     ]
    },
    "inline": {
     "local": [
      "bax-20220428.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bax-20220428_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bax-20220428_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "bax-20220428.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd"
     ]
    }
   },
   "elementCount": 37,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 6,
   "memberStandard": 2,
   "nsprefix": "bax",
   "nsuri": "http://www.baxter.com/20220428",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220428.htm",
      "contextRef": "idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Document and Entity Information Document",
     "role": "http://www.baxter.com/role/DocumentandEntityInformationDocument",
     "shortName": "Document and Entity Information Document",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bax-20220428.htm",
      "contextRef": "idff6e919e228401aa6dc0458e303f1b2_D20220428-20220428",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 8,
   "tag": {
    "bax_CommonStock1.00PerValueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, $1.00 Per Value [Member]",
        "label": "Common Stock, $1.00 Per Value [Member]",
        "terseLabel": "Common Stock, $1.00 Per Value"
       }
      }
     },
     "localname": "CommonStock1.00PerValueMember",
     "nsuri": "http://www.baxter.com/20220428",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_GlobalNotes04Due2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "0.4% Global Notes due 2024 [Member]",
        "label": "Global Notes 0.4% due 2024 [Member]",
        "terseLabel": "0.4% Global Notes due 2024"
       }
      }
     },
     "localname": "GlobalNotes04Due2024Member",
     "nsuri": "http://www.baxter.com/20220428",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_GlobalNotes13Due2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.3% Global Notes due 2025 [Member]",
        "label": "Global Notes 1.3% due 2025 [Member]",
        "terseLabel": "1.3% Global Notes due 2025"
       }
      }
     },
     "localname": "GlobalNotes13Due2025Member",
     "nsuri": "http://www.baxter.com/20220428",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_GlobalNotes13Due2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.3% Global Notes due 2029 [Member]",
        "label": "Global Notes 1.3% due 2029 [Member]",
        "terseLabel": "1.3% Global Notes due 2029"
       }
      }
     },
     "localname": "GlobalNotes13Due2029Member",
     "nsuri": "http://www.baxter.com/20220428",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_GlobalNotes173Due2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Notes 1.73% due 2031",
        "label": "Global Notes 1.73% due 2031 [Member]",
        "terseLabel": "Global Notes 1.73% due 2031"
       }
      }
     },
     "localname": "GlobalNotes173Due2031Member",
     "nsuri": "http://www.baxter.com/20220428",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "domainItemType"
    },
    "bax_GlobalNotes395Due2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global Notes 3.95% due 2030",
        "label": "Global Notes 3.95% due 2030 [Member]",
        "terseLabel": "Global Notes 3.95% due 2030"
       }
      }
     },
     "localname": "GlobalNotes395Due2030Member",
     "nsuri": "http://www.baxter.com/20220428",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityListingsExchangeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Listings, Exchange [Axis]",
        "terseLabel": "Entity Listings, Exchange [Axis]"
       }
      }
     },
     "localname": "EntityListingsExchangeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_ExchangeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383.",
        "label": "Exchange [Domain]",
        "terseLabel": "Exchange [Domain]"
       }
      }
     },
     "localname": "ExchangeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "exch_XCHI": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CHICAGO STOCK EXCHANGE, INC [Member]",
        "terseLabel": "CHICAGO STOCK EXCHANGE, INC"
       }
      }
     },
     "localname": "XCHI",
     "nsuri": "http://xbrl.sec.gov/exch/2021",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "domainItemType"
    },
    "exch_XNYS": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEW YORK STOCK EXCHANGE, INC. [Member]",
        "terseLabel": "NEW YORK STOCK EXCHANGE, INC."
       }
      }
     },
     "localname": "XNYS",
     "nsuri": "http://xbrl.sec.gov/exch/2021",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.baxter.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001628280-22-010921-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-22-010921-xbrl.zip
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MJV_B+@UQO9F R=#)Q'5^F&,0JZUI I8CL?X*6)_O6=Q^>+YH2JV!.(4/]9I
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M"@0#4N@J5:Q];4[1T1V#I!SJTUPI:YU[I(\Q :B^ 12^<GV.$]\E2$MP(
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MZL%30V[H_^;AO?X(Y/70Q'32^]9]!P>4,^9C(C>+Q4?CON<&)VZ4GPC;-)\
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MC*-W3+2I8C _0,<>.KRZX?K2B;#QA&]\7DED4_W%>:T07NF"C9U'G-. 1/(
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M\$1*?\@2PUF'B=.\^$N\SVTH3)AZ*(J$0$$%P*5/,^J=%_L!20[?P=.ZQ-#
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MB*]S)MX3;%YM>.BP <Z#)(RIK*8 DN#0*([[D?!NNM%)C8<(LG@W)<4>*_A
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MJT;$4T:WW,W#[[T[<G/;0Q?<]6>L5W+SM5<AU[V'$JEO)VKKG131,Z<^A66
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M^6K61JUW]D\##:76;AX 6XWZ_K'55&K-9/3Z@K4V17C],_9;<>J^CF+Y\@G
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M 6'&&%X(N  A-A3>AT"=@K5;CL>UHH1$^?I&:"Y(?4*>+V(D82WC<&%V?/7
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M[AFUGNC46YSSV+1/EQ:\?JY[(Q"U^M).T'@WA^X?#[T[$J90D-ONYQY1:^N
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MB<R%OV*9"P/,7)ABY@*\AB<O(/8,<S# IV$KF@/8EK8/RQJXSAB&<3R&MLK
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MX96%I'.)^K(6B)]&X*XIE>HLF_[S&3I EL+V9\+6GK<2/K/M6/^Q/>GNJ6%
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M0(WX,(2X.S6O"4CXY-'./)O=)]H9<:K<\1\\U!<');)8I*^[U.K:5>[:CQQ
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M=O'.>?IW\E!K0:(F\$\O[\>K_P]02P,$%     @ =SJ<5$J)V-28 P  J0\
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M]79O9*TRV-\[61O<V7@K:].X.O&N,_[.?GKU;/6-_2'X3+]Z]G]02P,$%
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M5M<#8EL6/@?K.AH73_=N"8KA?7[^:'F@^]/]:-KS1_\'4$L! A0#%     @
M=SJ<5"5 %8@460  ;M$% !8              ( !     &)A>"TR,#(R,#,S
M,7AE>#DY,2YH=&U02P$"% ,4    " !W.IQ4LE"8$BP8  "WO@  $
M        @ %(60  8F%X+3(P,C(P-#(X+FAT;5!+ 0(4 Q0    ( '<ZG%1*
MB=C4F ,  *D/   0              "  :)Q  !B87@M,C R,C T,C@N>'-D
M4$L! A0#%     @ =SJ<5.IDQ(0@"@  OTP  !0              ( !:'4
M &)A>"TR,#(R,#0R.%]D968N>&UL4$L! A0#%     @ =SJ<5')>HB Q$
M\YH  !0              ( !NG\  &)A>"TR,#(R,#0R.%]L86(N>&UL4$L!
M A0#%     @ =SJ<5/LK XZA"0   D\  !0              ( !'9   &)A
H>"TR,#(R,#0R.%]P<F4N>&UL4$L%!@     &  8 A@$  /"9      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
